DNA methylation and brain structure and function across the life course: a systematic review by Wheater, Emily N.w. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA methylation and brain structure and function across the life
course: a systematic review
Citation for published version:
Wheater, ENW, Stoye, DQ, Cox, SR, Wardlaw, JM, Drake, AJ, Bastin, ME & Boardman, JP 2020, 'DNA
methylation and brain structure and function across the life course: a systematic review', Neuroscience and
Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2020.03.007
Digital Object Identifier (DOI):
10.1016/j.neubiorev.2020.03.007
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Version created as part of publication process; publisher's layout; not normally made publicly available
Published In:
Neuroscience and Biobehavioral Reviews
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Journal Pre-proof
DNA methylation and brain structure and function across the life course:
a systematic review
Emily N.W. Wheater, David Q. Stoye, Simon R. Cox, Joanna M.
Wardlaw, Amanda J. Drake, Mark E. Bastin, James P. Boardman
PII: S0149-7634(19)30715-8
DOI: https://doi.org/10.1016/j.neubiorev.2020.03.007
Reference: NBR 3722
To appear in: Neuroscience and Biobehavioral Reviews
Received Date: 12 August 2019
Revised Date: 3 March 2020
Accepted Date: 5 March 2020
Please cite this article as: Wheater ENW, Stoye DQ, Cox SR, Wardlaw JM, Drake AJ, Bastin
ME, Boardman JP, DNA methylation and brain structure and function across the life course: a
systematic review, Neuroscience and Biobehavioral Reviews (2020),
doi: https://doi.org/10.1016/j.neubiorev.2020.03.007
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2020 Published by Elsevier.
 
 
1 
DNA methylation and brain structure and function across the life course: a systematic 
review 
 
Short running title: DNA methylation and brain imaging 
 
Emily N. W. Wheater1, David Q. Stoye1, Simon R. Cox2, Joanna M. Wardlaw3, Amanda J. 
Drake4, Mark E. Bastin3, James P. Boardman1,3* 
 
Affiliations 
1 Medical Research Council Centre for Reproductive Health, University of Edinburgh, United 
Kingdom. 
2 Department of Psychology, University of Edinburgh, United Kingdom. 
3 Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom. 
4 University/British Heart Foundation Centre for Cardiovascular Science, University of 
Edinburgh, United Kingdom. 
 
*Corresponding author: 
Professor James P Boardman (james.boardman@ed.ac.uk)  
Queen's Medical Research Institute (W1.26) 
47 Little France Crescent, 
Edinburgh, 
EH16 4TJ, 
UK. 
 
Postal addresses of authors 
Emily N. W. Wheater, David Q. Stoye, Amanda J. Drake, James P. Boardman: Queen’s 
Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, United 
Kingdom 
Simon R. Cox, Mark E. Bastin: Psychology Building, 7 George Square, Edinburgh, EH8 9JZ, 
United Kingdom 
Joanna Wardlaw: Chancellor’s Building, 49 Little France Crescent, Edinburgh, EH16 4SB, 
United Kingdom 
  
Jo
urn
al 
Pre
-pr
o
f
 
 
2 
Highlights 
 60 studies of association between DNAm and human brain MRI were identified 
 Differential DNAm is associated with brain structure and function throughout life 
 There is modest consistency between DNAm and image endophenotypes 
 Approaches for reducing heterogeneity in DNAm-MRI analyses are proposed 
 
Abstract 
 
MRI has enhanced our capacity to understand variations in brain structure and function 
conferred by the genome. We identified 60 studies that report associations between DNA 
methylation (DNAm) and human brain structure/function. Forty-three studies measured 
candidate loci DNAm; seventeen measured epigenome-wide DNAm. MRI features included 
region-of-interest and whole-brain structural, diffusion and functional imaging features. The 
studies report DNAm-MRI associations for: neurodevelopment and neurodevelopmental 
disorders; major depression and suicidality; alcohol use disorder; schizophrenia and 
psychosis; ageing, stroke, ataxia and neurodegeneration; post-traumatic stress disorder; and 
socio-emotional processing. Consistency between MRI features and differential DNAm is 
modest. Sources of bias: variable inclusion of comparator groups; different surrogate tissues 
used; variation in DNAm measurement methods; lack of control for genotype and cell-type 
composition; and variations in image processing. Knowledge of MRI features associated with 
differential DNAm may improve understanding of the role of DNAm in brain health and 
disease, but caution is required because conventions for linking DNAm and MRI data are not 
established, and clinical and methodological heterogeneity in existing literature is substantial.  
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1. Introduction 
 
A growing number of studies have investigated associations between epigenetic signatures 
and neuroimaging markers of human disease, behaviour and cognition. This area of research 
is motivated by the understanding that epigenetic processes contribute to brain development, 
ageing and disease, and they may mediate interaction between genomic predisposition and 
environmental pressures that modify brain structure and function.  
 
The term epigenetics refers to a set of molecular mechanisms that modulate the function of 
the genome in different cell types without altering the genome itself.  DNA methylation (DNAm) 
is one such mechanism whereby a methyl group is covalently added to cytosine residues in a 
Cytosine-phosphate-Guanine context (CpG). This is thought to alter the accessibility of a locus 
to transcriptional machinery or modifying proteins, thereby influencing gene expression. DNA 
methylation may also occur after an initial change in gene expression and function as a form 
of longer-term control (Jones, 2012). 
 
The pathogenesis of several genetic diseases with neurological phenotypes involve DNAm 
dysregulation. Rett syndrome is a severe neurological disorder characterised by regression of 
acquired skills, stereotypic movements, microcephaly, seizures, and intellectual disability. It 
results from a loss of function mutation in the X-linked methyl-CpG binding protein 2 gene 
(MECP2), which is a chromatin associated protein required for normal neuronal function 
throughout life. The loss of function mutation in MECP2 serves to reduce the binding affinity 
of MECP2 to methylated DNA with effects on regulation of gene expression at transcriptional 
and post-transcriptional levels (Lyst and Bird, 2015). Angelman syndrome is characterised by 
cognitive impairment, movement or balance disorder, typical abnormal behaviours, and 
impaired speech and language. It arises from a mutation or deletion of the maternal ubiquitin 
protein ligase 3A gene (UBE3A) and the neuronal tissue specific paternal imprinting of the 
gene that silences the paternal allele (Rangasamy et al., 2013). Fragile X syndrome arises 
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due to CGG triplet expansion within the FMR1 gene promoter which becomes 
hypermethylated and results in a reduction of gene expression (Wijetunge et al., 2013). In 
addition to these genetic neurological disorders associated with DNAm dysregulation, 
variation in DNAm has been implicated in the pathogenesis of a number of complex 
neurodevelopmental, neurological and psychiatric diseases including autism, schizophrenia, 
and problems associated with trauma and stress (De Rubeis et al., 2014; Grayson and 
Guidotti, 2013; Klengel et al., 2014; Oberlander et al., 2008; Palumbo et al., 2018).  
 
DNAm may be modifiable by environmental factors including physiological and emotional 
stress, child abuse, nutritional deprivation, and other lifestyle factors that operate from fetal 
life to old age (Cao-Lei et al., 2015; Del Blanco and Barco, 2018; Gouin et al., 2017; Heijmans 
et al., 2008; Joehanes et al., 2016; McGowan et al., 2009; Provenzi et al., 2018; Vidal et al., 
2014). As such, it has been proposed that environmentally-induced changes in DNAm may 
enable short-term survival adaptation, but may also induce adaptations that contribute to 
impaired development of neural networks and increased risk of pathology (Gluckman et al., 
2010; Hoffmann et al., 2017). 
 
Structural, diffusion and functional brain MRI enable the parsing of complex behavioural traits 
and diseases onto quantitative indicators of brain structure and function. Such imaging 
endophenotypes have been used to demonstrate the impact of common genetic variants on 
brain health and disease (Elliott et al., 2018), but the role of DNAm in contributing to brain 
structure and / or function, as opposed to being a consequence of changes in structure or 
function, is less certain. To obtain a comprehensive overview of the extent to which differential 
DNAm associates human behaviour and disease we performed a systematic review of studies 
that have analysed DNAm with quantitative brain MRI data. By doing so we aimed to provide 
a comprehensive summary of what is known about DNAm-MRI associative relationships 
across the life course, and to identify image features associated with differential DNAm. 
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Finally, we captured sources of heterogeneity in the extant literature to better inform the 
development of methods and conventions for analysing DNAm with MRI data.  
 
2. Materials and methods  
 
We performed a systematic literature search based on the PRISMA framework, according to 
a pre-registered protocol on PROSPERO (CRD42018090928).  
 
2.1 Search strategy 
Scopus, Web of Science, MEDLINE and EMBASE (via OVID) were searched in March 2018 
to identify studies that integrated DNA methylation and human in vivo MRI (for search strategy 
see supplementary material). The search was composed of three OR clusters that contained 
terms relating to the key domains, which were combined with AND: MRI neuroimaging AND 
Brain AND DNA methylation. Bibliographies were searched for additional studies. There were 
no language restrictions on the search. 
 
2.2 Screening and study selection 
Search results were imported to EndNote X8 prior to removal of duplicates and retrieval of full 
texts prior to import to Covidence software (https://www.covidence.org/home). Screening was 
carried out by ENWW and DQS independently and studies were included if they met the 
following criteria: report of primary results; recruited human participants of any age with in vivo 
neuroimaging and DNAm; investigated the relationship between brain imaging using MRI and 
epigenome-wide or loci specific DNAm. Exclusion criteria: no original data reported (reviews, 
abstracts, letters, and grey literature as defined by Grey Literature International Committee 
Guidance); no test of association between brain imaging findings and DNA methylation; 
analysis was carried out in animals or in post-mortem human tissue; DNAm-MRI analyses of 
central nervous system malignancy. 
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2.3 Data extraction 
ENWW extracted data for all included studies and DQS duplicated extraction for a subset of 
25%. Extraction included: participant characteristics, study design, method of DNAm 
ascertainment, MRI modality and image feature(s) of interest, and statistical method, 
consideration of cell sub-type composition includes cell sorting techniques or statistical 
methods to estimate and control for cell sub type composition and consideration of genotype 
or ancestry. The total number of participants per phenotypic category were estimated. Due to 
participant overlap in some studies, the largest study population reported was used to estimate 
the total number of participants.  
 
2.4 Risk of bias assessment 
In the absence of a validated quality assessment tool for studies linking DNAm with MRI data, 
we extracted data on study characteristics that might affect risk of bias: design, presence / 
absence of a comparator group; DNA source; candidate or epigenome-wide approach for 
evaluating differential DNAm; ascertainment of cell type composition; consideration of 
genotype; image processing methodology; and region-of-interest versus whole brain MRI 
analysis, and considered their prevalence in the epigenetic-neuroimaging literature. 
 
2.5 Data synthesis 
We provide a narrative synthesis structured around the type of association between DNAm 
and image feature, target population characteristics, tabulated, and categorised by disease. 
 
3. Results 
 
3.1 Overview of the literature 
Figure 1 is the PRISMA flow chart of study identification and inclusion. Our search strategy 
yielded 3442 in total: 3438 resulting from the search and an additional 4 papers were identified 
post search and were included. After removal of duplicates and exclusions at screening, 336 
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articles were eligible for full text evaluation. Of the full text articles that were screened for 
eligibility for inclusion, 276 were removed due to lack of eligibility. In total, 60 studies were 
included in this review (estimated 6775 participants): 34 (57%) included a control or 
comparator group. Table 1 summarises diseases and conditions in phenotypic categories, 
number of participants per category, MRI modality, and method used to analyse DNAm 
(EWAS or candidate loci). All studies report populations from resource rich settings: United 
States (25), United Kingdom (3), Germany (4), Switzerland (4), Germany and Switzerland (1), 
South Korea (7), Canada (3), Italy (2), Japan (1), China (2), Singapore (2), Republic of Ireland 
(2), Australia (2), Spain (1), Sweden (1).  
 
3.2 DNA methylation 
All studies used surrogate tissues to probe methylation status: blood  (n=46); saliva (n=12); 
one study reported using both blood and saliva, and one reported using blood/saliva/buccal 
cells (Ismaylova et al., 2017; Nikolova et al., 2014). The majority of studies did not report 
adjustments for cell type composition of samples used to estimate DNAm (n=48). 
 
Forty-three studies used a candidate gene analysis approach and 17 performed an 
epigenome-wide association study (EWAS). The majority of included studies that used a 
candidate gene approach measured methylation using bisulfite pyrosequencing (n=36). Three 
studies measured methylation at a candidate gene using the EpiTYPER® system (Haas et 
al., 2016; Shelton et al., 2017, 2016). One study carried out a restriction enzyme digest and 
sequencing to measure DNAm at a candidate site (McMillan et al., 2015). Three studies 
measured DNAm using Illumina arrays, and used the output to inform candidate gene DNAm-
MRI analyses (Sadeh et al., 2016; Walton et al., 2014; Wiemerslage et al., 2017). Overall 
nineteen candidate loci were studied. SLC6A4 (Na+/Cl- Dependent Serotonin Transporter) 
was the gene of interest in 11 studies; BDNF (member of nerve growth factor family), FKBP5 
(member of the immunophilin family) and OXTR (oxytocin receptor) were selected as 
candidate genes in four studies; NR3C1 (glucocorticoid receptor) in three studies; FMR1 
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(FMRP Translational Regulator 1), COMT (enzyme involved in catecholamine degradation) 
and DAT/SLC6A3 (Na+/K+ dependent dopamine transporter) in two studies. The following 
genes were selected candidates in one study: OXT (encodes oxytocin and neurophysin 1 
precursor protein), C9orf72 (thought to be a transcriptional regulator in the brain), CACNA1C 
(voltage gated calcium channel), DRD2 (dopamine receptor), KLF13 (transcription regulator), 
NCAPH2/LMF2 (encoding both a non-SMC subunit of the condensin II complex  and a lipase 
maturation factor protein from the same locus), PPM1G (member of the PP2C family of 
Ser/Thr protein phosphatases), HTR3A (member of the ligand-gated ion channel receptor 
superfamily), SKA2 (Spindle And Kinetochore Associated Complex Subunit 2), SOD 
(superoxide dismutase) and TESC (tescalcin – regulates cell pH by controlling H+/Na+ 
exchange across the plasma membrane). 
 
All of the EWAS studies used Illumina Infinium arrays to measure DNAm: Illumina 
HumanMethylation27 (n=6), Illumina 450 (n=13), and Illumina EPIC (n=1). These arrays 
measure methylation at 27 578, 485 512 and 866 836 CpG sites, respectively. Five studies 
investigated DNAm age, a method that uses a subset of CpG sites associated with age to 
investigate age and age acceleration (Chouliaras et al., 2018; Davis et al., 2017; Hodgson et 
al., 2017; Raina et al., 2017; Wolf et al., 2016). 
 
Of studies which only report DNAm at candidate genes, two reported that the sample used to 
measure DNAm was mononuclear blood cells (lymphocytes and monocytes) (Chouliaras et 
al., 2018; Ursini et al., 2011) whereas none of the studies that measured DNAm by bisulfite 
pyrosequencing reported correction for cell type composition. 12 of the 20 studies which used 
Illumina arrays performed a correction for cell type composition. Only one study reported direct 
counting of cell types included in their samples (Freytag et al., 2017).  
 
3.3.1 Magnetic Resonance Imaging 
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The majority of studies used 3T MRI scanners (n = 42); five studies used 1.5T scanners; five 
included participants scanned at 1.5T and 3T scanners; and eight studies did not report field 
strength. Many included studies carried out functional MRI (n=29), of which three studies also 
carried out structural analysis. Structural MRI, to investigate volumes, cortical morphology, 
and conventional clinical MRI measures, was used in 26 studies. Diffusion MRI to measure 
properties of white matter microstructure was used in nine studies, and MR angiography was 
used in one. 
 
3.3.2 MRI features associated with DNAm across studies 
Table 2 shows 10 MRI features that are associated with differential DNAm in two or more 
studies. The image features are: hippocampal volume (n=11); hippocampal functional 
connectivity/activity (n=4); amygdala functional connectivity/activity (n=9); PFC functional 
connectivity/activity (n=8); regional FA measures (n=6); cortical thickness (n=6); regional 
diffusion metrics (AxD/MD/RD) (n=5); global FA (n=2); and cortical volume (n=2). For most of 
these, differential DNAm occurred at different loci. However, amygdala functional 
connectivity/activity was associated with differential DNAm in SLC6A4 in six studies, and 
OXTR in two studies. PFC connectivity/activity was associated with DNAm in BDNF in two 
studies. Hippocampal volume was associated with FKBP5 DNAm in two studies. Activation 
within the prefrontal cortex in working memory tasks were associated with COMT DNAm in 
two studies. The studies all employed a candidate gene approach to DNAm analysis and 
directions of association were mixed across the studies.  
 
Six studies tested an association between SLC6A4 methylation and amygdala reactivity. Four 
out of five studies that reported associations between SLC6A4 methylation and the emotional 
face processing task assessed by fMRI in response to threat stimuli found positive 
associations with amygdala reactivity and connectivity (Ismaylova et al., 2018; Nikolova et al., 
2014; Schneider et al., 2018; Swartz et al., 2017). One study investigated resting state 
functional connectivity and reported a positive association between SLC6A4 methylation and 
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amygdala coupling with the salience network (Muehlhan et al., 2015). However, in a further 
study that investigated SLC6A4 methylation and brain activity in the context of both resting 
state connectivity and the emotional face processing task, there were no significant 
associations reported with regard to the amygdala either with regards to whole brain analysis 
or amygdala region-of-interest analysis (Ismaylova et al., 2017).The sixth study that reported 
an association between SLC6A4 and amygdala connectivity was also task-based fMRI, and 
used a visual emotional attention shifting paradigm (Frodl et al., 2015).These papers assessed 
DNAm within the promoter region of the SLC6A4 gene, with the exception of Schneider et al. 
2018, where a retrotransposon element, AluJb, was studied.  
 
Two studies reported significant associations between OXTR methylation and amygdala 
connectivity (Puglia et al., 2015; Ziegler et al., 2015). Each study used a different fMRI task 
paradigm: the first used a task employing words involving social phobia relevant verbal stimuli 
in a cohort of patients with social anxiety disorder (Ziegler et al., 2015); and the second used 
an emotional face- matching block-design task in a group of healthy study participants (Puglia 
et al., 2015). Both studies measured DNAm in blood but each targeted a different region of 
the OXTR gene in bisulfite sequencing. Ziegler et al. 2015 targeted exon 3 of the OXTR gene 
due to previous work demonstrating an association between methylation in this region and 
social cognition (Unternaehrer et al., 2012; Ziegler et al., 2015). Puglia et al. 2015 targeted a 
single CpG site at position -934 relative to the transcription start site, where methylation had 
previously been associated with autism spectrum disorder (Gregory et al., 2009; Puglia et al., 
2015). The directions of associations reported in these two studies were mixed, and may be 
explained by the variations in study design and participant characteristics. 
 
Two studies reported significant associations between BDNF methylation and PFC functional 
connectivity (Moser et al., 2015; Ursini et al., 2016). Moser et al. performed DNAm-MRI 
analysis in a combined group of analysis of study participants with PTSD, sub-threshold PTSD 
and healthy control women, and assessed neural response to a Modified Crowell Procedure 
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(Moser et al., 2015). The second study reported BDNF DNAm associations with PFC activity 
during a working memory task in a healthy group of study participants (Ursini et al., 2016). 
Both of these studies measured DNAm at different regions of the BDNF gene. Ursini et al. 
2016 measured BDNF DNAm in blood at a region containing the rs6265 SNP, which lies in a 
coding region of the gene, which may interact with environmental factors to modulate risk for 
schizophrenia, while Moser et al. 2015 measured BDNF promoter DNAm in saliva, where 
methylation has been associated with trauma associated psychiatric disease in children 
(Moser et al., 2015; Ursini et al., 2016). The directions of associations reported in these studies 
were mixed.  
 
Two studies reported associations between FKBP5 methylation and hippocampal volume 
(Klengel et al., 2013; Resmini et al., 2016). In study participants with childhood trauma related 
PTSD there was a negative correlation between FKBP5 methylation in blood and right 
hippocampal head volume (Klengel et al., 2013). In patients with Cushing’s syndrome there 
was a positive association between FKBP5 methylation in blood and bilateral hippocampal 
volume (Resmini et al., 2016). Both of these studies measured DNAm at glucocorticoid 
responsive regions of the FKBP5 gene, but report significant associations in different regions. 
Klengel et al. 2013 reported significant associations with intron 7, while Resmini et al. 2016 
reports a significant association with a CpG site within intron 2 (Klengel et al., 2013; Resmini 
et al., 2016).  
 
Two studies reported associations between COMT DNAm and PFC activation during working 
memory tasks (Ursini et al., 2011; Walton et al., 2014). The two studies assessed brain activity 
during different working memory tasks: the n-back task (Ursini et al., 2011); and the Sternberg 
Item Recognition task (Walton et al., 2014). The COMT gene encodes two isoforms of the 
catechol-O-methyltransferase enzyme: one soluble and one membrane bound, each with their 
own promoters, with the membrane bound isoform being the form most commonly found in 
the brain. Positive associations between MB-COMT promoter DNAm in blood and activity in 
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the left dlPFC and vlPFC (Broca’s area 45) during the Sternberg Item Recognition task were 
found in a group of participants including healthy controls and schizophrenia patients (Walton 
et al., 2014).  In the second study of healthy participants significant negative associations were 
reported between methylation at COMT rs4680 SNP in blood and activity in the bilateral PFC 
(BA 45/14 and BA47) during the n-back task in participants homozygous for the Val/Val allele 
at the rs4680 COMT SNP (Ursini et al., 2011). The difference in direction of associations 
reported by these two studies may be explained by the variations in study design and 
participant characteristics.  
 
3.4 Associations between DNAm and MRI features categorised by phenotype  
 
3.4.1 Neurodevelopment and neurodevelopmental disorders 
Table 3 summarises eight studies that focused on neurodevelopment: typical development; 
the impact of early life stress on young adulthood; BDNF polymorphism in early life; ADHD; 
preterm brain injury; hippocampal sclerosis in mesial temporal lobe epilepsy; birthweight 
discordance between twins and its impact on cortical anatomy. Four of the eight studies 
included a comparison group, and four were case series. Two studies report data from the 
Growing up towards Healthy Outcomes in Singapore (GUSTO) cohort study (Chen et al., 
2015; Guillaume et al., 2018). 
 
Two studies used a candidate gene approach and both reported positive associations, but 
between different MRI features and different genes: the first between DNAm at the SLC6A4 
promoter and cortical thickness in an uncontrolled case series of 102 children with ADHD 
(Park et al., 2015); and the second between DNAm at FKBP5 introns and dlPFC activation 
during the go no-go task in a case series of young adults with a history of early life stress 
exposure (Harms et al., 2017). The remaining six studies used the Illumina 450k array to 
measure DNAm, and all reported significant associations between DNAm at multiple loci and 
features including fractional anisotropy (FA), sub-cortical ROI volumes, cortical thickness, 
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volume and surface area (Casey et al., 2017; Chen et al., 2015, 2018; Guillaume et al., 2018; 
Long et al., 2017; Sparrow et al., 2016). Two studies reported associations between DNAm at 
SMOC2 and MRI brain imaging features (Chen et al., 2018; Guillaume et al., 2018). Guillaume 
et al. 2018 performed an EWAS in neonates and report an association between DNAm at this 
gene and FA in the left ventrolateral thalamus (Guillaume et al., 2018). Chen et al. 2018 
reported differential methylation and discordance in twin pairs discordant for ADHD diagnosis, 
and identified six probes associated with the SMOC2 gene which were differentially 
methylated and were associated with differences in striatum (among 48 probes that were 
differentially methylated with regard to striatum volume) (Chen et al., 2018). SMOC2 encodes 
SPARC-related modular calcium binding protein 2.  
 
Two studies reported an association between neonatal water diffusion properties and DNAm 
(Guillaume et al., 2018; Sparrow et al., 2016). In a case control study of preterm infants and 
term born controls principal component analysis of saliva DNAm identified a component that 
was associated with shape of the right corticospinal tract (Sparrow et al., 2016); and in 
neonates from the GUSTO cohort study there was an association between umbilical cord 
blood DNAm at the SMOC2 gene and FA in the left ventrolateral thalamus (Guillaume et al., 
2018). 
 
3.4.2 Major depressive disorder (MDD) and suicidality 
Table 4 describes 10 studies of MDD and 1 of suicidality. Seven studies had overlapping 
participants: five have some overlapping participants from an outpatient psychiatric clinic of 
Korea University Anam Hospital and community controls (Choi et al., 2015; K. Han et al., 2017; 
K. M. Han et al., 2017; Na et al., 2016; Won et al., 2016); and two other studies had 
overlapping participants (Booij et al., 2015; Frodl et al., 2015). Nine studies included a 
comparator group and 2 were case series of individuals with familial risk for MDD. 
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Ten of eleven studies used a candidate gene approach based on blood samples and one 
carried out EWAS on salivary DNA. Five candidate genes were studied in the context of MDD: 
SLC6A4 (n=5), BDNF (n=2), TESC (n=1), FKBP5 (n=1) and CACNA1C (n=1). The single 
EWAS study reported an association between DNAm age and hippocampal volume, noting 
that DNAm mediated the effect of cortisol on hippocampal volume (Davis et al., 2017). 
 
All four fMRI studies were task based. Two used the emotional face processing paradigm to 
investigate amygdala reactivity in relation to the SLC6A4 AluJb element or its promoter, and 
both report significant correlations between activation and SLC6A4 DNAm among cases 
(Schneider et al., 2018; Swartz et al., 2017). Another study reported a correlation between 
DNAm at the SLC6A4 and limbic system activation during a visual emotional attention shifting 
task in an analysis which pooled MDD cases and controls (Frodl et al., 2015). Together these 
studies suggest that SLC6A4 methylation positively correlates with limbic system reactivity in 
response to threat or negative emotional stimuli. However, these studies measured and 
reported SLC6A4 methylation at different sites, and analysed them differently. For example, 
Frodl et al used a summary mean measure across 11 CpG sites in the promoter, Swartz et al 
calculated a residualised change score from 20 CpG sites, and Schneider et al calculated 
mean methylation at the AluJb element of the promoter from 6 CpG sites (Frodl et al., 2015; 
Schneider et al., 2018; Swartz et al., 2017). The fourth fMRI study investigated brain 
responses to images that were associated with suicidal means in relation to DNAm in the 
CACNA1C transcription factor binding site, and reported differential brain activation in 
association with DNAm at two CpGs (Kim et al., 2017).  
 
3.4.3. Alcohol use disorder 
Table 5 summarises 4 studies of alcohol use disorder, all of which investigated DNAm in 
candidate genes in relation to task-based fMRI. Two were case-control study designs and two 
were uncontrolled case series. Three candidate genes were assessed: DRD2, SLC6A3/DAT 
and PPM1G. Three different tasks were used: testing impulse control, reactivity to alcohol 
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cues and processing of reward/punishment cues. Three of these studies measured DNAm in 
blood, and one in saliva. Three of the four studies reported positive correlations between 
functional activation in limbic system structures and DNAm among participants with alcohol 
use disorder (Bidwell et al., 2018; Ruggeri et al., 2015; Wiers et al., 2015). The remaining 
study found no significant correlations in the alcohol dependent cases, but did find negative 
correlations in functional activation in the nucleus accumbens and methylation at the SLC6A3 
promoter in the context of a monetary incentive delay task (Muench et al., 2018). 
 
3.4.4. Schizophrenia and psychosis 
Table 6 summarises seven studies of schizophrenia and psychosis, all of which included a 
comparator group. Six of the included studies use data from participants in the Mind Clinical 
Imaging Consortium (MCIC) all of whom have MRI, DNAm and SNP data available (Deng et 
al., 2016; Hass et al., 2015; Hu et al., 2018; Liu et al., 2015; Walton et al., 2014; Wang et al., 
2017).  
The majority of these studies measured blood DNAm on the Illumina HumanMethylation27 
array (n=4), and one study carried out a candidate gene analysis on blood MB-COMT DNAm. 
Five of these used the Illumina HumanMethylation27 array, and two carried out bisulfite 
pyrosequencing of two genes: OXTR and MB-COMT. fMRI was the most commonly used 
modality (n=5), followed by sMRI (n=3). Of these, one study used both modalities. fMRI tasks 
included: a sensorimotor task and the Sternberg Item Recognition Paradigm for working 
memory ( Hu et al., 2018; Walton et al., 2014). Two studies did not report the fMRI paradigm 
(Deng et al., 2016; Wang et al., 2017).  
 
3.4.5. Ageing, stroke, ataxia and neurodegeneration  
Table 7 summarises eight studies that investigated aspects of ageing, including healthy 
ageing, Alzheimer’s disease, minor cognitive impairment, stroke, WMH burden and C9orf72 
expansion and Fragile X Associated Tremor Ataxia Syndrome (FXTAS).  
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Imaging modalities used were as follows: dMRI (n=2), sMRI (n=5) d/sMRI (n=1). All studies 
used blood samples to measure DNAm. Five studies carried out candidate gene analysis and 
three measured DNAm in an epigenome-wide manner. The candidate genes studied were: 
C9orf72 (n=1), NCAPH2/LMF2 (n=1), FMR1 (n=2), SOD (n=1). Two studies carried out a 
longitudinal analysis as well as a cross-sectional analysis (McMillan et al., 2015; Swartz et al., 
2017). One of these showed, in a group of 11 C9orf72 expansion patients, that there was 
more rapid grey matter atrophy in the right hippocampus, right thalamus and left middle frontal 
cortex where there was decreased methylation in the expansion region (McMillan et al., 2015). 
The other found in 87 study participants that increases in SLC6A4 promoter methylation 
corresponded to increases in amygdala reactivity in response to threat related stimuli in task-
based fMRI (Swartz et al., 2017). Two studies that investigated associations between FMR1 
methylation and brain imaging in women with FXTAS had overlapping participants (Shelton et 
al., 2017, 2016). The three EWAS studies investigated DNAm age in relation to its 
associations with brain imaging features (Chouliaras et al., 2018; Hodgson et al., 2017; Raina 
et al., 2017). Two of these three studies investigated dMRI: one found a negative association 
of FA with epigenetic age acceleration, while the other found a negative association between 
global mean diffusivity (MD) and Hannum age and a positive association between FA and 
Hannum age (Chouliaras et al., 2018; Hodgson et al., 2017). In an analysis with sMRI a 
positive association was found between WMH burden category and DNAm age acceleration 
(Raina et al., 2017). 
 
3.4.6. Post-traumatic stress disorder 
Table 8 summarises seven studies that were carried out in participants with PTSD (Table 6). 
Several studies had overlapping participants. Three studies report associations in an 
overlapping group of participants: PTSD cases and non-PTSD controls, where the case 
population was mothers who have experienced interpersonal violence (IPV) (Moser et al., 
2015; Schechter et al., 2017, 2015). Two further studies had overlapping participants – a 
cohort of trauma exposed veterans (Sadeh et al., 2016; Wolf et al., 2016).  An additional group 
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of veterans was also studied in relation to PTSD (McNerney et al., 2018). A further study 
recruited women who had experienced early life trauma to investigate associations between 
DNAm and sMRI features (Klengel et al., 2013). Five candidate genes were studied: NR3C1 
(n=2), SKA2 (n=1), BDNF (n=1), FKBP5 (n=1), 5HT3A (n=1). All three modalities were 
employed to investigate neuroimaging features: dMRI (n=1), sMRI (n=3), fMRI (n=3). Overlap 
in study populations lay between two studies which measured DNAm using the Illumina 450k 
array (Sadeh et al., 2016; Wolf et al., 2016). Wolf et al. (2016) carried out analysis of DNAm 
age while Sadeh et al. (2016) carried out a candidate gene analysis of SKA2 (Sadeh et al., 
2016; Wolf et al., 2016). McNerney et al. (2018) measured DNAm at the NR3C1 gene using 
bisulfite pyrosequencing (McNerney et al., 2018). All three of the articles investigating a 
population of mothers who have experienced IPV studied candidate genes: NR3C1, BDNF 
and 5HT3A (Moser et al., 2015; Schechter et al., 2017, 2015). All three used fMRI, with two 
using the same task (Modified Crowell procedure), and one using a unique task video stimulus 
depicting neutral, menacing, and male-female prosocial interactions (Moser et al., 2015). The 
two studies that reported on IPV PTSD mothers in relation to the modified Crowell procedure 
showed positive associations between DNAm at NR3C1 and BDNF and cluster activation in 
vmPFC OFC posterior cingulate cortex (Moser et al., 2015; Schechter et al., 2015).  
 
3.4.7. Miscellaneous: healthy adults, socio-emotional processing, Cushing’s syndrome 
Two of the included studies in this section investigated patient populations, and the remainder 
reported healthy participants. One case-control study investigated DNAm-MRI in Cushing’s 
Syndrome patients, and another case series study investigated social anxiety disorder 
(Resmini et al., 2016; Ziegler et al., 2015). Both studies discovered significant correlations 
between DNAm and neuroimaging findings. Fourteen studies in this section adopt a candidate 
gene analysis approach, with 1 being epigenome-wide (Table 9). The candidate genes studied 
were: COMT (n=1), OXTR (n=3), NR3C1 (n=1), SLC6A4 (n=5), OXT (n=1), FKBP5 (n=1), 
KLF13 (n=1), BDNF (n=1). DNAm was measured in the following tissues: saliva (n=3); blood 
(n=10); blood/saliva/buccal (n=1); saliva and blood (n=1). Two MRI modalities are represented 
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in this section: sMRI (n=3), and fMRI (n=10), and two studies used both modalities (s/fMRI 
(n=2). fMRI tasks included: N back task, social phobia associated verbal stimuli, emotional 
perspective, emotional attribution, social perception, emotional face processing, responses to 
high calorie versus low calorie foods. 
 
The three studies that investigated associations with OXTR methylation measured DNAm at 
two different positions: one in exon 3 and the other two at a CpG site -934 base pairs upstream 
of the TSS which has consistent methylation across blood and brain tissues (Jack et al., 2012; 
Puglia et al., 2015; Rubin et al., 2016; Ziegler et al., 2015). While these studies all used fMRI, 
they also used different tasks: social phobia related verbal stimuli, the emotional face matching 
task, and the social perception task (where objects move in ways to suggest animacy or 
random movement). One study investigated OXTR DNAm in exon 3, which had previously 
been implicated in social cognition, in a patient population with social anxiety disorder (Ziegler 
et al., 2015). The other two investigated healthy participants; one of these was in the context 
of social perception and individual variability in social perception (displays of animacy) (Jack 
et al., 2012; Puglia et al., 2015). 
 
Five papers analysed associations between SLC6A4 methylation and neuroimaging features. 
They included fMRI (n=4) and sMRI (n=2). fMRI studies used resting state and/or emotional 
face processing tasks. Ismaylova et al. (2017) estimated DNAm from three different surrogate 
tissues: blood, saliva, and buccal cells  and reported that right lateral parietal area (RLP) 
resting state connectivity with the lateral occipital cortex and frontal poles has a positive 
association with SLC6A4 DNAm (Ismaylova et al., 2017). Muehlhan et al. (2015) found 
positive associations between functional coupling between amygdala and nodes of the 
salience network with DNAm of the SLC6A4 promoter in blood (Muehlhan et al., 2015). In the 
emotional face processing task, two studies report positive association between SLC6A4 
methylation and amygdala reactivity/connectivity in response to threat/fear related faces. 
Nikolova et al reported a positive relationship between saliva DNAm at SLC6A4 and left 
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amygdala reactivity to threat stimuli, while Ismaylova et al reported that twins with higher saliva 
DNAm at SLC6A4 display greater connectivity between ACC and left amygdala (Ismaylova et 
al., 2018; Nikolova et al., 2014).  The two studies that used sMRI both found positive 
associations between DNAm at SLC6A4 and grey matter volumes (Dannlowski et al., 2014; 
Ismaylova et al., 2017). However, they did not replicate each other by identifying the same 
brain regions as being associated even when using the same tissue to estimate DNAm. 
 
4. Discussion 
 
This systematic review of 60 studies involving approximately 6775 participants suggests that 
differential DNAm may be associated with MRI features of brain structure and / or function for 
conditions / diseases within the following categories: neurodevelopment and 
neurodevelopmental disorders; MDD and suicidality; alcohol use disorder; schizophrenia and 
psychosis; ageing, stroke, ataxia and neurodegeneration; post-traumatic stress disorder; 
healthy adults and socio-emotional processing. We found that 10 image features were 
associated with differential DNAm in two or more of the 60 studies. However, quantitative 
synthesis of DNAm-MRI associations was not possible due to the lack of consistency in DNAm 
findings, and / or heterogeneity in image features across studies. While the results presented 
here could provide new insights into the role of DNAm in health and disease across the life 
course, caution is required because the clinical and methodological heterogeneity of included 
studies was large. We identified the following sources of methodological heterogeneity and 
potential sources of bias: variable inclusion and characterisation of comparator groups in study 
designs; use of different tissues as a surrogate for brain; variation in methods for estimating 
DNAm and ascertainment of cell type composition; lack of control for genotype; and variations 
in image processing methodology and selected MRI features. 
 
4.1 Study populations and comparator group validity 
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Twenty-six studies (43%) did not include a comparator group, and some others recruited 
cases and controls but combined the groups in DNAm-MRI analysis or restricted DNAm-MRI 
analysis to one group only. These issues limit inference about disease association. Several 
aspects of study design that are fundamental to good epidemiology should be adopted in 
future DNAm-MRI studies to reduce potential sources of bias and enable maximum inference. 
These include detailed descriptions of participant selection, the population from which they 
were selected, and the method used to select. Not only is this important for understanding 
case definition, but also because research participation is influenced by social class, 
education, and ethnicity, and some of these factors may influence DNAm (Stafford et al., 
2013). The same descriptive standards should be applied to comparator groups to ensure 
clinical validity, and attention should be given to matching comparator groups for ethnicity and 
age because both affect DNAm (Fraser et al., 2012; Heyn et al., 2013; Horvath, 2013; Talens 
et al., 2010).   
 
4.2 Surrogate tissues for brain DNAm and cell composition 
Surrogate tissues include blood and saliva buccal cell samples. This is important when 
interpreting data because of tissue and cell heterogeneity in DNAm patterns. Buccal cells, a 
major cell type found in saliva, have been proposed to have more validity than blood as a 
surrogate tissue for brain since they have a common embryological cell lineage, both being 
derived from the ectoderm germ layer (Smith et al., 2015). One study that ascertained DNAm 
from three sample types (blood, saliva, buccal - buccal cells and saliva samples are collected 
differently) found that DNAm obtained from non-blood surrogate tissues most strongly 
associated with brain processes in living humans in the context of fMRI study (Ismaylova et 
al., 2017). This is consistent with a previous study in postmortem brain tissue in animal 
models, which found that saliva and brain are more similar in their DNA methylation patterns 
than are blood and brain (Lowe et al., 2013). Surrogate tissues have heterogeneous cell 
compositions which can impact the DNAm signature of the sample: blood comprises 
lymphocytes, neutrophils, basophils, monocytes and eosinophils; and saliva contains 
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predominantly buccal cells but can include leukocytes. Crucially, the compositions of both 
surrogates are influenced by disease status. Hence, adjustment for cell composition should 
be considered in DNAm analysis.  
 
4.3 Candidate gene versus epigenome-wide approaches 
Forty-three included studies in this review used a candidate gene analysis approach, with 
candidacy most often rooted in knowledge or hypotheses about the biological underpinnings 
of the target disease. The majority of candidate gene studies focused on promoter regions, 
which risks neglect of other important regulatory regions, because it limits research to currently 
understood genomic elements that have a clear role in gene expression regulation.  
 
Although there are inherent sources of bias in the candidate approach, it has been suggested 
that candidate gene studies can provide a useful starting point for hypothesis construction for 
example by investigating candidates that have emerged from the GWAS literature (Nikolova 
and Hariri, 2015). However, we did not find that candidate selection was based on the GWAS 
literature in the majority of studies. For example, SLC6A4 was the candidate gene in eleven 
studies. SLC6A4 encodes a serotonin transporter responsible for serotonin re-uptake from the 
synapse, and is one of the targets for the serotonin reuptake inhibitor class of antidepressants. 
Despite the importance of this gene product in the pharmacology of depression, recent GWAS 
studies report no association between candidate polymorphisms at SLC6A4 (or a number of 
other candidate genes) and major depression (Border et al., 2019). This suggests that 
candidate genes that encode important pharmacological targets are not necessarily 
aetiologically significant. This is not to say that the methylation status of these genes is 
irrelevant: for example, it could be useful for investigating medication response, or as a 
biomarker. Frodl et al carried out an DNAm-MRI analysis with medication status as a 
covariate, and but found that this did not modify their findings regarding SLC6A4 methylation 
and brain function in MDD patients and controls, while Booij et al have reported differential 
methylation at the SLC6A4 promoter in association SSRI exposure (Booij et al., 2015; Frodl 
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et al., 2015). In a human population of MDD no difference was found in methylation between 
medication free subjects and those on medication in a post mortem study (Sabunciyan et al., 
2012). These uncertainties suggest that further research into association between medication 
exposure and DNAm is warranted, and that hypothesis formation around candidate genes 
should be explicit in terms of theorised mechanism of disease or biomarker development. 
Further, mechanistic studies are crucial to aid our understanding of the interaction between 
DNAm and disease or therapy. 
 
The rationales given for the selection of candidate genes for DNAm-MRI analysis were varied. 
Several studies selected candidates based on prior unbiased analyses in relation to 
phenotype (Kim et al., 2017; Ruggeri et al., 2015; Sadeh et al., 2016). For example, both 
PP1MG and SKA2 were identified in EWAS analyses (Ruggeri et al., 2015; Sadeh et al., 
2016), and CACNA1C was identified from a hypothesis free Methyl-Seq (Kim et al., 2017). 
Other candidate genes were chosen because they have a strong genetic link to the patient 
population being studied, such as C9orf72 expansion in ALS-clinic patients and FMR1 in 
FXTAS patients (McMillan et al., 2015; Shelton et al., 2017, 2016). For the most part candidate 
genes were selected because their gene products are considered key components of a 
pathway of relevance to a condition or phenotype studied. NR3C1 and FKBP5, the genes that 
encode the glucocorticoid receptor and FK506 binding protein (which regulates glucocorticoid 
receptor sensitivity), are both involved in cortisol signalling and were selected in studies 
investigating stress response or stress related neuropsychiatric conditions such as PTSD or 
MDD, or in Cushing’s Syndrome where cortisol is known to be dysregulated.  BDNF, which 
encodes for brain derived neurotrophic factor, was studied in association to MDD, PTSD and 
working memory. COMT encodes catechol-O-methyltransferase, an enzyme that degrades 
catecholamines such as dopamine, epinephrine and norepinephrine, was the candidate gene 
in studies investigating DNAm-MRI in the context of working memory in schizophrenia and in 
healthy participants. OXTR encodes the receptor for oxytocin and was selected in studies that 
investigated an aspect of emotional or social processing. SLC6A4 encodes the serotonin 
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reuptake transporter and is a target for the serotonin reuptake inhibitor class of anti-
depressants. It was the selected candidate gene in studies of MDD and ADHD patients and 
emotional processing, and resting state amygdala activity.  
 
Seventeen studies used an EWAS approach. There was no overlap between differentially 
methylated regions identified using this method versus the selected candidate gene approach 
for any of the phenotypic categories, which highlights the value of epigenome-wide 
approaches for unbiased investigation of the putative role of DNAm in brain structure and / or 
function. However, one study which employed an epigenome-wide approach to DNAm 
analysis identified COMT and SLC6A3 as being negatively associated with right amygdala 
volume in neonates homozygous for BDNF rs6265 Met/Met allele (Chen et al., 2015). Both of 
these genes were selected as candidates in other studies but associations were reported in 
different populations with regards to age and clinical background, and with different image 
features (Muench et al., 2018; Ursini et al., 2011; Walton et al., 2014; Wiers et al., 2015). Many 
of the studies that utilised epigenome wide methods for measuring DNAm did not go on to 
report on individual loci. In future studies whole genome-based approaches could play an 
important role in generating novel candidates and pathways for future research that could 
provide mechanistic insight into pathogenesis.   
 
 
4.4 Interindividual variability, effect of genotype, and temporal stability 
Sources of variability that are crucial for understanding of how changes in DNAm associate 
with endophenotypes include interindividual variability which may be stochastic, genetic or 
environmental in origin, and temporal stability (Lancaster et al., 2018). Twin studies are useful 
for separating genetic and environmental contributions to variability, and several are included 
in the DNAm-MRI literature to date (Casey et al., 2017; Chen et al., 2018; Ismaylova et al., 
2018). Twenty-four studies controlled for genotypic effects, for example by covarying for single 
nucleotide polymorphisms (SNPs), or for the first PC of the variance in genome wide genetic 
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data. This is because variation in DNAm may be explained partly by common genetic variation, 
such as a SNP that removes a methylation site. Therefore, genotyping in DNAm-MRI analyses 
is necessary for determining whether epigenetic associations with brain structure and function 
are genotype-specific, or whether associations are independent of genotype. 
 
The stability of some epialleles varies over time with dynamic methylation and demethylation 
at CpG sites occurring in typical development and ageing, and in response to environmental 
exposures (Lancaster et al., 2018). Only fifteen studies reported the timing of DNAm sampling 
in respect to MRI acquisition; we suggest that this information is included in future studies 
because it is required to compare study populations and interpret phenotypic associations. 
Longitudinal investigation could be used to establish the temporal stability of methylation at a 
genomic region or site, the impact of medication, and for assessing potential causal 
relationships.  
 
All of the included studies carried out cross-sectional analysis and two additionally carried out 
longitudinal analysis. Three other studies performed mediation analysis to assess causal 
relationships (Casey et al., 2017; Freytag et al., 2017; Harms et al., 2017). Studies designed 
to investigate association or causation should report the magnitude of differential DNAm 
between groups since the described changes in DNAm are often small and the biological 
relevance of these remains uncertain. Ultimately however, differential DNAm-MRI data will 
need to be interpreted in the wider context of mechanistic studies of gene expression in order 
to make inferences about causality. For example, experiments that demonstrate changes in 
gene expression associated with the differential methylation patterns reported from DNAm-
MRI studies would be an important first step in dissecting causality, although it is important to 
note that changes in DNAm may actually occur as a consequence of changes in gene 
expression.  
 
4.5 Neuroimaging considerations 
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Structural and functional quantitative neuroimaging features have been included in this review, 
assessed using sMRI, fMRI and dMRI. Others have emphasised the importance of selecting 
image features that represent a deficient or pathological phenotype when investigating 
associations between DNAm and MRI  (Lancaster et al., 2018). Five DNAm-MRI associations 
recurred in two or more studies (SLC6A4 and amygdala reactivity; OXTR and amygdala 
reactivity; BDNF and PFC function; FKBP5 and hippocampal volume; COMT and PFC 
function), and a narrative synthesis of these demonstrates that there were mixed directions of 
associations, which may be explained by the variation in where in a genomic region DNAm 
was measured and in which tissue, in tasks employed during fMRI and in participant 
characteristics. A variety of fMRI paradigms have been used to probe brain function in this 
field, such as resting state and emotional processing, and dMRI studies have used different 
diffusion gradient encoding schemes and strengths (b-values) to measure the mobility of water 
molecules in vivo. A further layer of complexity is added in terms of differences in image 
processing pipelines such as CIVET (http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET), 
FreeSurfer (https://surfer.nmr.mgh.harvard.edu) and SPM (https://www.fil.ion.ucl.ac.uk/spm) 
for sMRI; and voxel based methods e.g. TBSS (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS) or 
tractography methods e.g. probabilistic neighbourhood tractography (http://www.tractor-
mri.org.uk/tractography) for analysis of dMRI (Ad-Dab’bagh et al., 2006; Anblagan et al., 2015; 
Bastin et al., 2010; Clayden et al., 2007, 2006; Fischl, 2012; Smith et al., 2006). In the future, 
it will be necessary to form consensus and harmonisation about the optimal acquisition 
protocols and analysis pipelines to allow findings from different groups to be combined more 
readily. Initiatives such as the ENIGMA consortium which aims to understand brain structure, 
function and disease using brain imaging and genetic data from groups around the world are 
an important step in this direction. 
 
4.6 Strengths and limitations 
This systematic review has several strengths. It was based on a predefined protocol and 
followed standard guidelines with rigorous screening of >3,400 articles and without language 
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or publication year restrictions. Our analysis was based on 60 studies examining healthy 
individuals and a wide range of neurological and psychiatric diseases in more than 6,000 
patients across the life course. This provided a detailed overview of a growing body of 
literature linking DNAm and MRI data types, and enabled us to identify the key sources of 
methodological variation that should be addressed as standards and conventions in DNAm-
MRI analyses become established. 
Our study also has limitations. First, there was substantial clinical and methodological 
heterogeneity which prohibited quantitative synthesis for any single phenotype category, or 
MRI feature. Second, in the absence of validated tools for assessing quality and risk of bias 
in DNAm-MRI analyses, we were unable to evaluate these issues quantitively. 
 
4.7 Conclusion 
There is some evidence of association between differential DNAm and human brain structure 
and / or function across the life course. However, varied methodologies used to acquire and 
analyse DNAm-MRI data prevent quantitative synthesis. The development of standards and 
conventions for studies linking DNAm with MRI data is required, with particular focus on: 
detailed case and comparator group definition; surrogate tissue type; adjustment for cell 
composition and common genetic variation; consistent approaches to DNAm estimation using 
whole genome approaches; and use of image acquisition protocols, analysis pipelines and 
image feature selection that best support pooled analyses that are likely to be required to 
achieve statistical power for EWAS-neuroimaging studies. In summary, this review has found 
that: differential DNAm is associated with image features of brain structure and function in 
health and disease across the life course (using data from over 6,000 individuals); evidence 
that differential DNAm is associated with specific image features is modest; and it has 
identified specific sources of sample and methodological heterogeneity in existing DNAm-MRI 
analyses. We anticipate that identification of these will expedite rational development of 
analytic methods in this emerging field so that researchers might more rapidly design studies 
that support causal inference. 
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Abbreviations used in tables 
ACR, anterior corona radiata 
AD, alcohol dependence 
AxD, axial diffusivity 
ADC, apparent diffusion coefficient 
aMCI, amnesic mild cognitive impairment 
BCC, body of the corpus calllosum 
CC, corpus callosum 
CLASP, Constrained Laplacian-based Automated Segmentation with Proximities 
CSF, cerebral spinal fluid 
CST, corticospinal tract 
DG, dentate gyrus 
DMR, differentially methylated region 
FA, fractional anisotropy 
FXTAS, Fragile X Associated Tremor Ataxia Syndrome 
GCC, genu of corpus callosum 
GM, grey matter 
HC, healthy controls 
HS, hippocampal sclerosis 
IFG, inferior frontal gyrus 
IT, inferior temporal 
MD, mean diffusivity 
MDD, major depressive disorder 
MFG, middle frontal gyrus 
mOFC, medial orbitofrontal cortex 
MRF, Markov Random Field 
MTLE, mesial temporal lobe epilepsy 
NAcc, nucleus accumbens 
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NR, not reported 
PCR, posterior corona radiata 
PHC, parahippocampal cingulum 
PNT, probabilistic neighbourhood tractography 
PTR, posterior thalamic radiation 
RD, radial diffusivity 
RLP, right lateral parietal area 
RS, resting state 
SFG, superior frontal gyrus 
STG, superior temporal gyrus 
TBSS, tract-based spatial statistics 
vlPFC, ventrolateral prefrontal cortex 
vlThalamus, ventrolateral thalamus 
WB, whole brain  
WMH, white matter hyperintensities 
 
Gene names 
SKA2, Spindle and Kinetochore Associated Complex Subunit 2 
SLC6A4, Solute Carrier Family 6 Member 4 
BDNF, Brain Derived Neurotrophic Factor 
FKBP5, FK506 Binding Protein 51 
OXTR, Oxytocin Receptor 
NR3C1, Nuclear Receptor Subfamily 3 Group member 1 
FMR1, Fragile X Mental Retardation 1 
COMT, Catecholamine Transferase 
DAT/SLC6A3, Dopamine Transporter/Solute Carrier Family 6 Member 3 
OXT, Oxytocin/Neurophysin 1 Prepropeptide 
C9orf72, Chromosome 9 Open Reading Frame 72 
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CACNA1C, Calcium Voltage-Gated Channel Subunit Alpha1 C 
DRD2, Dopamine Receptor 2 
KLF13, Kruppel Like Factor 13 
NCAPH2, Non-SMC Condensin II Complex Subunit H2 
LMF2, Lipase Maturation Factor 2 
PPM1G, Protein Phosphatase Magnesium Dependent 1 Gamma 
HTR3A, 5-Hydroxytryptamine Receptor 3A 
SOD, Superoxide Dismutase 
TESC, Tescalcin 
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Figure legend 
Figure 1. PRISMA flow diagram of studies 
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Table 1. Overview of studies 
Disease or condition, 
number of studies  
 
Number of 
participants 
MRI modality 
(structural, 
functional, 
diffusion) 
 
Epigenetic method: Epigenome-wide (EW) or candidate 
(candidate loci) 
Neurodevelopment and 
neurodevelopmental disorders† 
n=8 
715 5 sMRI 
1 fMRI 
2 dMRI 
6 EW 
2 candidate (SLC6A4, FKBP5) 
Major depressive disorder and 
suicidality 
n=11 
922§ 4 sMRI 
4 fMRI 
2 dMRI 
1 sMRI/dMRI 
1 EW 
10 candidate (BDNF, SLC6A4, FKPB5, CACNA1C, TESC) 
Alcohol use disorder  
n=4 
921 4 fMRI 0 EW 
4 candidate (PPM1G, DAT/SLC6A3, DRD2) 
Schizophrenia and psychosis 
n=7 
456§ 
 
2 sMRI 
4 fMRI 
1 sMRI/fMRI 
5 EW 
3 candidate (OXTR, BDNF, COMT) 
Ageing, stroke, ataxia and 
neurodegeneration 
n=8 
1456§ 5 sMRI 
2 dMRI 
1 sMRI/dMRI 
3 EW 
5 candidate (C9orf72, FMR1, SOD, NCAPH2/LMF2) 
Post-traumatic stress disorder 
n=7 
450§ 3 sMRI 
3 fMRI 
1 dMRI 
1 EW 
6 candidate (SKA2, NR3C1, HTR3A, BDNF, FKBP5) 
Miscellaneous‡ 
n=15 
1855 3 sMRI 
10 fMRI 
2 sMRI/fMRI 
1 EW 
14 candidate (COMT, OXTR, NR3C1, SLC6A4, OXT, FKBP5, 
KLF13, BDNF) 
 
†Includes studies of typical development, twin birth weight discordance, BDNF Val66Met polymorphism, preterm birth, early life stress, 
attention deficit hyperactivity disorder, medial temporal lobe epilepsy 
‡Healthy adults, emotion processing, social anxiety disorder, Cushing’s syndrome 
§Estimate due to possible sample overlap within phenotypic category. 
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Table 2. Associations between image features and DNAm 
 
Image Feature 
(number of studies) 
Differential DNAm: gene or feature 
Global fractional anisotropy (n=2) 
 
DNAm age (Horvath) 
DNAm age (Hannum) 
Regional fractional anisotropy (n = 6) 
 Corpus callosum 
 
 
 Ventrolateral thalamus 
 Right anterior corona radiata 
 Right parahippocampal cingulum 
 
SLC6A4 
FMR1 
DNAm age (Hannum) 
SMOC2 
BDNF 
TESC 
Regional radial, mean or axial diffusivity (n = 5) 
 Inferior and middle cerebellar peduncle 
 Corpus Callosum 
 Right anterior corona radiata 
 Right parahippocampal cingulum 
 
FMR1 
DNAm age (Hannum) 
SLC6A4 
BDNF 
TESC 
Amygdala functional connectivity 
(n=9) 
SLC6A4 
SLC6A4 
SLC6A4 
SLC6A3/DAT 
SLC6A4 
OXTR 
OXTR 
SLC6A4 
SLC6A4 
Hippocampal functional connectivity  
(n = 4) 
SLC6A4 
Cluster of genes identified through EWAS (Wang et al 2017)* 
Cluster of genes identified through EWAS (Hu et al 2018)* 
BDNF 
Prefrontal cortex functional connectivity 
(n = 8) 
FKBP5 
MB-COMT 
BDNF 
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NR3C1 
HTR3A 
COMT 
SLC6A4 
BDNF 
Hippocampal volume 
(n = 11) 
BDNF 
SLC6A4 
TESC 
DNAm age (Horvath) 
Cluster of genes identified through EWAS (Hass et al 2015)* 
OXTR 
DNAm age (Hannum) 
FKBP5 
NR3C1-1F 
SLC6A4 
FKBP5 
Cortical volume 
(n = 2) 
Cluster of genes identified through EWAS (Casey et al 2017)* 
Cluster of genes identified through EWAS (Liu et al 2015)* 
Cortical thickness 
(n = 6) 
SLC6A4 
BDNF 
FKBP5 
FMR1 
SKA2 
Independent component of DNAm (Freytag et al 2017) 
PFC (volume/thickness) 
(n = 2) 
OXTR 
SKA2 
*See Tables 3-9 for list of genes included in clusters identified by EWAS 
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Table 3. Neurodevelopment and neurodevelopmental disorders  
Author, 
Country 
Sample 
characteristics 
 condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for 
cell sub-type 
distribution 
 Consideration of 
genotype 
 MRI field 
strength 
 Modality  
 Image feature(s) 
 Analysis method 
Main Findings 
 
 
Chen et al., 
2015 
Singapore † 
 
 BDNF Val66Met 
polymorphism in 
GUSTO study 
 237 cases 
(133M) 
 Mean gestational 
age 38.7 weeks 
 Epigenome-wide: 
Illumina 450 array 
 Umbilical cord 
blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: yes 
 1.5T 
 Structural, T2 
 Volume of total 
brain and 18 ROIs  
 MRF model 
segmentation 
 19% of total variable CpGs were significantly associated 
with the volume of the left hippocampus for Val/Val 
neonates.  
 5% of total variable CpGs were associated with left 
hippocampal volume in the Met/Val genotype group 
 3% of total variable CpGs were significant in the Met/Met 
genotype group. 
Park et al., 
2015 
South Korea 
 ADHD 
 102 participants 
(77M) 
 Mean age 8.9 
years  
 Candidate: 
SLC6A4 promoter 
(185bp region) 
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: yes  
 3T 
 Structural, T1 
 Cortical thickness 
 CLASP algorithm 
(Kim et al., 2005) 
 Negative association between DNAm of SLC6A4 CpGs 5-
8 in the promoter region and cortical thickness in the right 
STG, middle occipital gyrus, lingual gyrus, inferior occipital 
gyrus, precentral gyrus, MTG, cuneus, and cingulate 
gyrus. 
Sparrow et 
al., 2016 
United 
Kingdom 
 Preterm birth  
 36 preterm 
infants (<32 
weeks’ 
gestation); 36 
term controls 
 Mean age at 
assessment: 
 Epigenome-wide: 
Illumina 450 array 
 Saliva 
 Cell type 
composition: no 
 Consideration of 
genotype: yes 
 3T 
 Diffusion 
 Tract shape in 8 
major tracts. 
 Probabilistic 
Neighbourhood 
Tractography 
(PNT) 
 95% of the variance in the preterm methylome was 
explained by 23 principal components; the 6th principal 
component explained 2.9% of the variance of DNAm data 
in the preterm group and was associated with right CST 
topology. Jo
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39.7 weeks for 
controls and; 
40.0 weeks for 
cases 
Casey et al., 
2017 
Canada 
 Cortical anatomy 
in monozygotic 
twin cohort  
 52 twin pairs 
(22M) 
 Mean age 15.7 
years 
 
 Epigenome-wide: 
Illumina 450 array 
 Saliva 
 Cell type 
composition: yes 
 Consideration of 
genotype: NR 
 3T 
 Structural, T1 
 Cortical thickness, 
surface area, 
volume 
 CIVET automated 
analysis pipeline  
 
 23 probes mediate the relationship between birthweight 
discordance and cortical volume, including annotated 
probes found in 13 genes: PRPF3, RELN, EXOC2, 
LEFTY2, CAST, SNK1G2, TRIM5, ABR, TNF, C6orf10, 
FREM2, GABPA and EFNA5; 15 probes mediate the 
relationship between birthweight discordance and cortical 
surface area, including annotated probes found in 9 
genes: TMCO3, TRIM15, KDM2A, EPDR1, PARP14, 
PBLD, RELN, ACACA and CASZ1.  
 No probes significantly mediated the relationship between 
birthweight discordance and cortical thickness 
discordance. 
Long et al., 
2017 
China 
 HS in MTLE 
 Cases n=30 
(18M); controls n 
= 30 (18M) 
 Cases mean 
25.3 years; 
controls mean 
28.2 years 
 Epigenome-wide: 
Illumina 450 array 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR  
 Image acquisition: 
NR 
 Hippocampal 
sclerosis on 
conventional MRI 
Subgroup analysis: MTLE patients with (n = 9) or without 
HS (n = 14). 
 From top 10 differentially methylated probes: DNAm in 
SLC12A7, SRC, PLIN5 had a positive association with 
HS; DNAm in PCNT, CEACAM21, PCGF3, BAT2 
displayed a negative association with HS. 
 Genes from top 10 positively associated with HS: 
RASAL3, PFDN6:WDR46, UBN1:GLYR1, TRIM49, 
ACVR1B. 
 Genes from the top 10 negatively associated with HS: 
SPIRE2, NKD1, TNFRSF11B 
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Harms et al., 
2017 
United 
States 
 Early life stress 
exposure on 
adult outcome 
 33 participants 
(15M) 
 Mean age 20.5 
years 
 Candidate: 
FKBP5, CpG sites 
in intron 7, 5, and 
2 
 Saliva 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T 
 fMRI task: go-no 
go task 
 dlPFC activation 
 Analysis of 
Functional 
NeuroImages  
 Negative association between DNAm of intron 5 of FKBP5 
and activation in the dlPFC in the go no-go task.  
 CpG8 of intron 5 mediates the relationship between 
childhood stress and dlPFC activation. 
 
Chen et al., 
2018 
United 
States 
 ADHD 
 15 monozygotic 
twin pairs (12M), 
discordant for 
ADHD 
 Mean 9.7 years 
 
 Epigenome-wide: 
Illumina 450 array 
 Blood 
 Cell type 
composition: yes 
 Consideration of 
genotype: yes  
 1.5T 
 Structural, T1 
 Cerebral cortex, 
cerebellum, 
caudate, putamen, 
thalamus volumes 
 FreeSurfer 
Subset of 14 MZ twins: 
Of the 67 genes with intrapair probe DNAm which 
associated with volume discordance in the cerebellum, 49 
were negatively associated. Of the 48 genes associated 
with the striatum, 38 were negatively associated, while of 
the 78 associated with the thalamus 44 were negatively 
associated. 
Guillaume et 
al., 2018 
Singapore † 
 
 
 GUSTO birth 
cohort 
 114 participants 
 7-10 days post 
birth 
 Epigenome-wide: 
Illumina 450 array 
 Umbilical cord 
blood 
 Cell type 
composition: yes 
 Consideration of 
genotype: NR 
 1.5T,  
 Diffusion 
 FA 
 Voxel based 
comparison of FA 
maps 
EWAS a significant association between probe cg19641625 
in the SMOC2 gene locus, with FA in the left vlThalamus.  
 
† Overlapping cohorts (GUSTO study) 
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Table 4. Major depressive disorder and suicidality 
Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for 
cell sub-type 
distribution 
 Consideration of 
genotype 
 MRI field 
strength 
 Modality  
 Image feature(s) 
 Analysis method 
Main Findings 
 
 
Choi et al., 
2015 
South Korea 
† 
 
 MDD 
 Cases, n=60 
(13M); controls, 
n=53 (17M) 
 Cases, mean 
41.9 years; 
controls, mean 
41.2 years 
 Candidate: BDNF, 
4 CpGs in the 
promoter region 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 Diffusion 
 FA/RD/AxD of 7 
white matter 
tracts  
 Tract Based 
Spatial Statistics 
(TBSS)  
 Cases: negative association between DNAm of CpG4 and 
FA of the right ACR, AxD of right ACR is negatively 
associated with BDNF DNAm. RD was not significantly 
associated with BDNF DNAm. 
 Controls: no significant positive associations. 
Booij et al., 
2015 
Republic of 
Ireland ‡ 
 
 
 
 MDD 
 Cases, n=33 
(10M); controls, 
n=36 (15M) 
 Cases, mean 
40.3 years; 
controls, mean 
35.3 years 
 Candidate: 
SLC6A4, CpGs 5-
15 found 214–625 
bp upstream of the 
gene promoter  
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes  
 3T 
 Structural, T1 
 Whole 
hippocampal and 
sub-hippocampal 
volumes 
 FreeSurfer 
 Whole group: negative predictive value of hippocampal 
volume and sub-volumes (CA2/3 and DG, and CA1) and 
SLC6A4 DNAm (average and site specific – CpG 5&6, CpG 
11&12) 
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Frodl et al., 
2015 
Republic of 
Ireland ‡ 
 
 MDD 
 Cases, 
n=25(7M); 
controls, 
n=35(13M) 
 Cases, mean 
41.6 years; 
controls, mean 
35.6 
 
 Candidate: 
SLC6A4, promoter  
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 fMRI task: Visual 
emotional 
attention shifting 
 Whole brain 
 SPM8 
 
 Whole group: when shifting from emotional valence to 
geometric properties there is a negative association 
between DNAm and activation in the right Rolandic 
operculum and insula, right superior temporal lobe, and 
pons; when shifting from negative to neutral emotional 
valence, there is positive association between DNAm and 
activation in the left anterior insula and inferior frontal 
operculum 
 Controls: When looking at emotionally negative stimuli 
versus neutral stimuli, there was a positive association 
between DNAm and more activation in the bilateral 
hippocampus, left inferior operculum, fusiform gyrus and 
amygdala regions. 
Na et al., 
2016 
South Korea 
† 
 
 
 MDD 
 Cases, n=65 
(11M); controls, 
n=65 (15M) 
 Cases, mean 
42.5 years; 
controls mean 
40.3 years 
 Candidate: BDNF, 
4 CpGs in the 
promoter region 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes  
 3T 
 Structural, T1 
 Cortical thickness 
 FreeSurfer 
 Cases: negative association between CpG2/4 and cortical 
thickness in the right rostral middle frontal, mOFC cortical 
thicknesses and left lingual, STG and SFG cortices. 
Negative association between CpG2 and cortical thickness 
in the right IT and pericalcarine and left rostral middle frontal 
cortices. Negative association between CpG4 and cortical 
thickness in the right cuneus, precuneus and post central 
cortices and left frontal pole cortices. 
 Controls: no significant associations found. 
Won et al., 
2016 
South Korea 
† 
 
 
 
 MDD 
 Cases, n=35 
(10M); controls, 
n=49 (15M) 
 Cases, mean 
40.3 years; 
controls mean 
41.1 years 
 Candidate: 
SLC6A4, 5 CpGs 
in the promoter 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype NR 
 3T   
 Diffusion 
 FA/MD/AxD/RD 
 TBSS 
 Cases: negative association between SLC6A4 DNAm and 
FA/AxD in the BCC (medication naïve).  
 Controls: negative association between SLC6A4 DNAm and 
GCC FA, and positive association with RD. 
 Associations between BCC FA/AxD and CpG3 DNAm are 
higher in the cases compared to controls. Jo
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K. Han et al., 
2017  
South Korea 
† 
 
 
 MDD 
 Cases, n=114 
(24M); controls, 
n=88 (27M) 
 Cases, mean 
43.5 years; 
controls, mean 
39.9 years 
 Candidate: 
FKBP5, intron 7 
rs1360780, 2 
CpGs investigated 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype: yes  
 3T   
 Structural, T1 
 GM 
volumes/cortical 
thickness of 14 
cortical/subcortica
l regions 
 FreeSurfer 
 FKBP5 C homozygote group (patients and controls) (n = 
118): positive association between DNAm of CpG1 and 
cortical thickness in the right transverse frontopolar gyrus.  
 
Kim et al., 
2017  
South Korea 
 
 Suicidality 
 Cases (suicide 
attempters), 
n=14 (1M), 
controls, n=22 
(9M) 
 Cases, mean 
31.9 years, 
controls, 33.6 
years 
 Candidate: 
CACNA1C, 11 
CpG sites in DMR 
in a transcription 
factor binding site 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 fMRI task: 
participants 
shown pictures of 
facial emotion 
and objects 
relating to suicidal 
means 
 Activation in 4 left 
hemisphere 
regions 
 SPM5 
 Cases: in knife vs neutral landscape contrast positive 
association between CpG4/6 DNAm and brain activation in 
the left thalamus, MFG, IFG. 
 Controls: positive association between CpG6 DNAm and 
activation in the left MFG and IFG. 
K. M. Han et 
al., 2017 
South Korea 
† 
 
 
 MDD 
 Cases, n=84 
(13M); controls, 
n=61(17M) 
 Cases, mean 
43.4 years; 
controls, mean 
38.6 years 
 Candidate: TESC, 
rs7294919 locus 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype: yes   
 3T   
 Diffusion 
 Structural 
 Diffusion 
parameters of the 
PHC 
 Hippocampal 
subfield volumes 
 Global PNT 
 Cases: negative association of FA and positive association 
of RD with CpG3 DNAm in right PHC. 
 Controls: no significant associations. 
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Swartz et al., 
2017  
United 
States 
 
 Family history of 
depression  
 Cases n=94 
(51M); controls 
n=89(46M);  
 Wave 1, mean 
13.5 years; wave 
2, mean 15.6 
years 
 Candidate: 
SLC6A4 - 20 CpG 
sites in promoter 
region 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype: yes   
 
 3T   
 fMRI task: 
emotional face 
processing  
 Amygdala 
reactivity  
 SPM8 
 Subgroup (n=87), longitudinal analysis: SLC6A4 promoter 
DNAm increases over time is associated with increases in 
left centromedial amygdala reactivity when participants 
viewed faces with fearful expressions in contrast to 
geometric shapes. 
 
Davis et al., 
2017 
United 
States 
 High/low familial 
MDD risk among 
females 
 High risk, n=24; 
low risk, n=22 
 High risk, mean 
12.9 years; low 
risk, mean 12.1 
years 
 Epigenome-wide: 
Illumina EPIC, 
Horvath DNAm 
age 
 Saliva 
 Cell type 
composition: yes  
 Correction of 
genotype: NR 
 1.5T/3T 
 Structural, T1 
 Hippocampal and 
amygdala 
volumes 
 FreeSurfer 
Whole group analysis: 
 Negative associations between DNAm age residual and left 
hippocampal volume.  
 Accelerated DNAm age mediates the effect of cortisol on 
left hippocampal volume.  
Schneider et 
al., 2018 
Germany 
 MDD 
 Cases, n=137 
(57M); controls, 
n=189 (83M) 
 Cases, mean 
37.4 years; 
controls, mean 
35.6 years  
 Candidate: 
SLC6A4 AluJb 
element 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes 
 3T 
 fMRI task: 
emotional face 
processing 
(threat/fearful 
faces) 
 Amygdala 
reactivity 
 SPM8 
 Whole group analysis: Significant interaction of amygdala 
activity with DNAm and diagnosis. 
 Cases: positive association between AluJb DNAm and 
activity in the right amygdala. No effect of DNAm on 
bilateral amygdala reactivity 
 Controls: no significant associations 
 
† Overlapping cohorts 
‡ Overlapping cohorts  Jo
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Table 5. Alcohol use disorder 
Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for cell 
sub-type 
distribution 
 Consideration of 
genotype 
 MRI field 
strength 
 Modality  
 Image 
feature(s) 
 Analysis 
method 
Main Findings 
 
 
Ruggeri et 
al., 2015 
United 
Kingdom 
 Alcohol exposure 
(IMAGEN cohort) 
 n=499(222M) 
 Mean age 14 
years 
 Candidate: 
PPM1G, 3’ UTR 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes 
 3T  
 fMRI task: stop 
signal task - 
impulse control 
 BOLD 
responses in 2 
ROIs  
 MarsBaR 
(SPM8) 
Subset of whole sample (n=393) 
 Positive association between PPM1G DNAm and BOLD 
response in the right subthalamic nucleus in the stop 
success versus go success contrast 
 No association with right IFG activation 
Wiers et al., 
2015 
United 
States 
 Alcohol 
dependence 
 Cases n=38 (M); 
controls, n=17 (M) 
 Cases, mean age 
44.4 years; 
controls, mean 
42.7 years 
 Candidate: 
SLC6A3/DAT - 12 
CpG sites in 
promoter region (-
1037 to -829) 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T  
 fMRI task: cue 
reactivity task, 
alcohol elicited 
response 
 Reactivity in 4 
ROIs 
 MarsBaR 
(SPM8) 
 Cases: positive association between alcohol elicited 
amygdala reactivity (in contrast to soft drink) and DAT 
DNAm found only in cases with low depression scores 
(n=29)  
 
Bidwell et al., 
2018 
United 
States 
 Alcohol 
dependence 
 383 (238M) 
 Mean age 30.1 
years (range 21-
56) 
 Candidate: DRD2, 
6 CpGs in promoter 
region (-126 to -
189) 
 Saliva 
 3T  
 fMRI task: cue 
reactivity task, 
alcohol elicited 
response 
 ROI analysis: Positive association between DRD2 DNAm 
and alcohol elicited activation in striatum: right NAcc, 
bilateral putamen and bilateral caudate. 
 WB analysis: positive associations between DRD2 DNAm 
and alcohol elicited response in: left superior temporal, 
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 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 BOLD contrasts 
of 10 ROIs and 
WB analysis 
 SPM8 
middle temporal, insula, postcentral, supramarginal, 
putamen regions. 
Muench et 
al., 2018 
United 
States 
 Alcohol 
dependence 
 Cases, 
n=45(35M); 
controls, n=45 
(22M) 
 Cases: mean 43.3 
years; controls: 
36.2 years 
 Candidate: 
SLC6A3/DAT, 48 
CpGs 
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T  
 fMRI task: 
Monetary 
incentive delay 
task  
 BOLD 
responses in 
bilateral NAcc  
 AFNI 
 Cases: no significant associations 
 Controls: negative association between SLC6A3 promoter 
DNAm and NAcc activation during the anticipation of both 
high and low monetary loss. The effects were driven by 2 
CpGs located at positions -1,001 and -993 from the TSS in 
the promoter of SLC6A3.  
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Table 6. Schizophrenia and psychosis 
Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for cell 
sub-type 
distribution 
 Consideration of 
genotype 
 MRI field 
strength 
 Modality  
 Image feature(s) 
 Analysis method 
Main Findings 
 
 
Walton et al., 
2014 
United States 
† 
 
 Schizophrenia or 
schizophrenifor
m disorder 
 Cases, 
n=82(62M); 
controls, 
n=102(62M) 
 Cases, mean 
33.8 years; 
controls 32.7 
years 
 Candidate: MB-
COMT, 864bp 
upstream from TSS 
of membrane 
bound isoform of 
COMT 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes  
 1.5T and 3T 
 fMRI task: 
Sternberg item 
recognition 
paradigm - 
working memory 
task. 
 BOLD response 
in dlPFC and 
exploratory whole 
brain analysis 
 fMRIB (FSL) 
Whole group: 
 ROI analysis: positive association between MB-COMT 
promoter DNAm and left dlPFC activation;  
 Whole brain analysis: positive association between MB-
COMT promoter methylation and left dlPFC and vlPFC 
(BA45), left premotor and primary sensory cortex. No effect 
in R dlPFC. 
No effect of diagnosis.  
Liu et al., 2015 
United States 
† 
 
 Schizophrenia, 
schizophrenifor
m or 
schizoaffective 
disorder  
 Cases, n=94; 
controls, n=106 
 Cases, mean 
34.7 years; 
controls, mean 
32.5 years 
 Epigenome-wide: 
Illumina Infinium 
HumanMethylation
27 Array 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 1.5T and 3T  
 Structural, T1 
 Volumes of 
cortical and 
subcortical 
regions  
 FreeSurfer 
 Negative association between the 7th DNAm component 
and the 1st brain volume component: 
Brain volume component - left cerebellar cortex, right 
cerebellar cortex 
Methylation component - C1orf65, MCCC1, EPHA3, 
CDX1, RAET1L, LR8, STMN2, GATA4, NALP6, KCNK10, 
ADRA1D, NPDC1, MCHR1 
Hass et al., 
2015 
 Schizophrenia   Epigenome-wide: 
Illumina Infinium 
 1.5T and 3T   
 Structural, T1 
 Alterations in the DNAm state of genes within the hsa-miR-
219a-5p targets are associated with hippocampal volume 
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United States 
† 
 
 Cases, n=103 
(75M); Controls, 
n=111(71M) 
 Cases: mean 
34.6 years; 
controls, mean 
32.1 years 
HumanMethylation
27 Array 
 Blood 
 Cell type 
composition: yes 
 Consideration of 
genotype: yes 
 fMRI: Sternberg 
Item Recognition 
Paradigm - 
working memory 
task. 
 Hippocampal 
volume, STG 
thickness 
 Working memory 
load dependent 
neural activity 
(percentage 
BOLD signal 
change) in the 
dlPFC 
 FreeSurfer 
 fMRIB (FSL) 
changes (has-miR-219a-5p target gene set: KIAA0182, 
PKNOX1, TRAF7, CBFA2T3, EPHA4, MKNK2, DDAH1, 
ESR1, AKAP13, PHACTR2, SLC31A1, KBTBD8, ADD2, 
ERGIC1, RBM24, KIAA0240, NEK6, THRB, SCN5A, 
TGFBR2, FZD4, SEMA4G) 
 STG thickness: miR-513 gene set sig enriched (NES = 
1.7636) with an FDR q value of 0.2404 (based on positive 
association between DNAm data and phenotype) 
 None of the predicted miRNA target gene sets was 
significantly enriched in association with working-memory 
load-dependent neural activity in the dlPFC.  
Deng et al., 
2016 
United States 
† 
 
 
 
 Schizophrenia  
 Case, 
n=80(60M); 
Controls, n=104 
(66M) 
 Cases, mean 34 
years; controls, 
mean 32 years 
 Epigenome-wide: 
Illumina Infinium 
HumanMethylation
27 Array 
 Tissue sampled: 
blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 NR 
 fMRI 
 NR 
 NR 
 Small concordance between fMRI data and DNAm data.  
 Prediction accuracy of schizophrenia cases was improved 
by incorporating the two data types versus prediction 
models using one or the other. 
Rubin et al., 
2016 
United States 
 
 
 Schizophrenia 
and Bipolar 
disorder 
 Case, 
n=167(75M); 
controls, 
n=75(37M) 
 Age 
 Candidate: OXTR - 
methylation 
measured at a site 
934bp upstream of 
TSS 
 Blood 
 Cell type 
composition: NR 
 3T 
 Structural, T1 
 Volumes of 
prefrontal regions 
and temporal 
limbic regions  
 FreeSurfer 
 Schizophrenia: positive association between OXTR DNAm 
and volumes of the left OFC, and right fusiform gyrus and 
negative association with the right hippocampus. 
 Bipolar disorder: positive association between DNAm and 
right parahippocampal gyrus volume.  
 Schizoaffective disorder (men): Negative association 
between OXTR DNAm and left MFG volume. 
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Schizophrenia: 
Women (n=22): 
mean 39 years; 
Men (n=35): 
mean 22 years 
Schizoaffective 
disorder: Women 
(n=19) mean 37 
years; Men 
(n=15) mean 38 
years 
Bipolar disorder:  
Women (n=51) 
mean 36 years; 
Men (n=25) mean 
26 years  
Controls: Women 
(n=38) mean 36 
years; Men 
(n=37) mean 39 
years 
 Consideration of 
genotype: NR 
 Controls: negative association between OXTR DNAm and 
left amygdala, right MFG and IFG volumes. 
Wang et al., 
2017 
United States 
† 
 
 Schizophrenia 
 Cases, 
n=80(60M); 
Controls, n=104 
(66M) 
 Cases: mean 34 
years; controls 
mean 32 years 
 
 Epigenome-wide: 
Illumina Infinium 
HumanMethylation
27 Array 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 
 NR 
 fMRI 
 NR 
 NR 
 Positive association between fMRI and DNAm modules in 
cases.  
 Associations in controls do not reach statistical 
significance. 
 DNAm module: ANKRD15, ATP6V0A4, C1orf116, 
C1orf172, C21orf56, CCNA1, CREB3L3, FLJ11017, 
HOXA4, HTN3, KIF27, LDHD, PAGE5, PDIA2, RCBTB2, 
RPL26L1, TMEM100 
 fMRI module: midcingulate area, parahippocampal gyrus, 
postcentral gyrus, supramarginal gyrus, angular gyrus, 
precuneus, superior temporal gyrus  Jo
urn
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Hu et al., 2018 
United States 
† 
 
 
 
 
 Schizophrenia  
 Cases, n=79; 
controls, n=104 
 Age: NR 
 
 Epigenome-wide: 
Illumina Infinium 
HumanMethylation
27 Array 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 Field Strength: 
NR 
 fMRI task: 
Sensorimotor task  
 NR 
 NR 
 
 Positive association between DNAm and fMRI data  
 DNAm: 31 CpG sites that correspond to 30 genes 
 fMRI (7 ROIs): left inferior frontal gyrus (pars triangularis), 
left hippocampus, right inferior occipital gyrus, bilateral 
fusiform gyrus, right middle temporal gyrus, left inferior 
temporal gyrus 
 
† Mind Clinical Imaging Consortium  
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Table 7. Ageing, stroke, ataxia and neurodegeneration 
Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for cell 
sub-type 
distribution 
 Consideration of 
genotype 
 MRI field strength 
 Modality  
 Image feature(s) 
 Analysis method 
Main Findings 
 
 
McMillan et 
al., 2015 
United States 
 C9orf72 
expansion 
 Cases, n=20; 
Controls, n=25 
 Cases: mean 
61.9 years; 
controls: mean 
6138 years 
 Candidate: C9orf72 
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T  
 Structural, T1 
 Grey matter density 
 Randomise (FSL) 
 
 C9orf72 expansion group: positive association between 
C9orf72 DNAm and grey matter density in the right 
hippocampus and thalamus and left premotor cortex. 
 Longitudinal analysis (n=11): GM atrophy progresses more 
rapidly over time with decreased C9orf72 DNAm in 
patients with C9orf72 expansion 
Shelton et al., 
2016 
Australia † 
 
 Fragile X 
associated 
tremor ataxia 
syndrome 
(FXTAS) 
 Cases, n=19F; 
controls, n=17F 
 Cases: mean 
39.4 years; 
controls, mean 
39.8 years 
 Candidate: FMR1 - 
exon 1 CpG1 and 
CpG2; intron 1 
CpG6/7, CpG8/9; 
CpG10-12 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 Structural, T1  
 Regional cortical 
thickness from 
bilateral MFG and 
SFG and inferior 
parietal gyrus  
 FreeSurfer 
 Premutation group: positive associations between 
methylation of FMR1 CpG6/7 or CpG1 or CpG10-12 and of 
cortical thickness in the left inferior parietal gyrus, middle 
frontal gyrus, and right middle frontal gyrus, superior frontal 
gyrus. Negative association between methylation in the 
intronic region with white matter hyperintensities.  
 Controls: negative associations between FMR1 DNAm at 
CpGs 2, 6/7, 10–12 and cortical thickness in frontal lobe 
regions: left middle frontal gyrus and right superior frontal 
gyrus Jo
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Zhou et al., 
2016 
China 
 Cerebral 
infarction 
 Cases, 
n=83(45M); 
controls, 
n=94(52M) 
 Cases: mean 
61.6 years; 
controls: mean 
61.6 years 
 Candidate: 
Extracellular SOD 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 Field strength: NR 
 MR Angiography 
 Area of cerebral 
infarction; cerebral 
arteriosclerosis 
 Analysis: NR  
 Dependence between large/small area of cerebral 
infarction and extent of extracellular SOD DNAm.  
 Negative but non-significant association between 
arteriosclerosis severity and extracellular SOD DNAm 
Shinagawa et 
al., 2016 
Japan 
 Alzheimer’s/aM
CI 
 Cases 58(27M): 
AD, n=30; aMCI 
n=28  
 Cases, mean 
71.9 years 
 Candidate: 
NCAPH2/LMF2 
promoter – 
representative CpG 
site 
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 1.5T 
 Structural, T1 
 VBM Grey matter/ 
VSRAD Z-score 
(hippocampal 
atrophy grade)  
 SPM8, 
DARTEL/VSRAD  
 Extent of grey matter atrophy non-significant for 
associations with NCAPH/LMF2 promoter DNAm.  
 Positive association between DNAm of NCAPH2/LMF2 
and severity of hippocampal atrophy.  
Hodgson et 
al., 2017 
United States 
 Ageing 
 Cases N=376 
 Mean 45.5years  
 Epigenome-wide: 
Illumina 450 array, 
Horvath DNAm age 
 Blood 
 Cell type 
composition: yes  
 Consideration of 
genotype: yes  
 3T  
 Diffusion  
 FA  
 TBSS 
 Negative association of FA with epigenetic age 
acceleration.  
Raina et al., 
2017 
United States 
 
 Cerebral white 
matter 
hyperintensities  
 N=713(257M) 
 Mean age at 
MRI was 61.8 
years; mean age 
 Epigenome-wide; 
Illumina 450k array, 
Hannum/Horvath 
DNAm age 
 Blood 
 Cell type 
composition: yes 
 1.5T 
 Structural, T1/T2  
 White matter 
hyperintensities 
 Non-automated 
counting 
 Positive association between WMH burden and DNAm age 
acceleration: high WMH burden category was associated 
with DNAm age acceleration, whereas low WMH burden 
was not. 
 No individual probe reached significance in any analysis. 
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at DNA sampling 
59.3 years 
 Consideration of 
genotype: yes 
Shelton et al., 
2017 
Australia † 
 
 FXTAS 
 Cases n=20 F; 
controls, n=20F 
 Cases mean 
40.1 years; 
controls mean 
39.1 years 
 Candidate: FMR1 –
exon 1 CpG1 and 
CpG2; intron 1 
CpG6/7, CpG8/9; 
CpG10-12  
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T   
 Diffusion 
 FA, MD in ROIs 
 TBSS (FSL) 
 Premutation group: negative association between inferior 
and middle cerebellar peduncle’s MD and CpG1 
 Control: negative association between BCC FA and 
CpG6/7 
Chouliaras et 
al., 2018 
United 
Kingdom 
 
 N = 47(39M) 
 Cognitively 
intact, mean 
72.8 years; 
cognitively 
impaired, mean 
72.3 years (s.d. 
6.02) 
 Epigenome-wide: 
Illumina 450k array, 
Horvath/Hannum 
DNAm age 
 Blood 
 Cell type 
composition: yes 
 Consideration of 
genotype: NR 
 3T  
 Structural, T1/ 
 Diffusion 
 total brain, 
hippocampal, CSF, 
GM volumes, WMH 
 FA, MD   
 Voxel wise 
statistical analysis, 
BIANCA (WMH 
detection)/ FSL 
 No associations were observed between the Horvath 
epigenetic clock and any of the imaging variables tested 
 Candidate gene testing did not find any associations that 
survived correction for multiple comparisons. 
 Negative association between global MD and Hannum 
age, and positive association between global FA and 
Hannum age.  
 
† Overlapping cohort 
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Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for cell 
sub-type 
distribution 
 Consideration of 
genotype 
 MRI field strength 
 Modality  
 Image feature(s) 
Analysis method 
Main Findings 
 
 
Klengel et al., 
2013 
United States 
 Childhood 
trauma related 
PTSD 
 Cases n=56(F) 
 Cases, mean 
age 28.5 mean 
years 
 Candidate: FKBP5 - 
4 intronic regions, 
CpG island of TSS 
and a region 
upstream of the 
TSS 
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: yes  
 3T   
 Structural, T1  
 Amygdala/Hippoca
mpal volume 
 Amygdala and 
hippocampal 
segmentation 
(Pruessner et al., 
2000) 
 Negative association between FKBP5 (mean at intron 7 bin 
2) DNAm and right hippocampal head volume in a subset 
of the cohort (n=34).  
Moser et al., 
2015 
Switzerland † 
 
 Inter-personal 
violence related 
PTSD  
 Controls, n= 
20F; 
Subthreshold 
PTSD, n = 8F; 
IPV-PTSD 
diagnosis, n = 
18F 
 Age - (sample of 
68 mothers with 
saliva): Mean 
34.3 years (s.d. 
5.8 years)  
 Candidate: BDNF 
mean methylation of 
4 CpGs found in 
exon IV 
 Saliva 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T 
 fMRI task: Modified 
Crowell Procedure  
 Contrast of brain 
activity when 
mothers watched 
their own and 
unfamiliar children 
during scenes of 
separation vs play 
 SPM8 
Whole group analysis: 
 Positive associations between BDNF promoter mean 
methylation and DNAm and cluster activation in the 
following clusters: in left vmPFC, OFC, sgACC; right 
vmPFC, OFC; posterior cingulate cortex. 
 Negative associations between BDNF promoter mean 
methylation and cluster activation in the following clusters:  
right hippocampus, right parahippocampal gyrus, right 
fusiform gyrus; left precuneus; right precuneus; left 
cerebellum; right STG. Jo
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Schechter et 
al., 2015 
Switzerland † 
 
 
 Inter-personal 
violence related 
PTSD  
 Cases, n=28; 
controls n=17 
 Cases, median 
35.1 years; 
controls, median 
35.5 years 
 Candidate: NR3C1 
– mean methylation 
of 13 CpGs 
 Saliva 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T   
 fMRI task: Modified 
Crowell Procedure  
 Batch 
programming 
based on SPM8 
Whole group analysis: 
 Positive associations between DNAm of NRC31 and 
cluster activation in vmPFC OFC, right gyrus rectus; left 
dlPFC; left dlPFC, left precentral gyrus; dmPFC; left 
precuneus, posterior cingulate cortex 
 Spearman’s correlations between each of the 13 CpG sites 
and neural activity in prefrontal cortex regions during 
separation vs. play did not reach statistical significance  
Sadeh et al., 
2016 
United States 
‡ 
 PTSD  
 Cases: a subset 
(n=145) of 
cohort size 
n=200(182M) 
 Mean 31.8 years 
 Candidate: SKA2–3’ 
UTR. (Illumina 
probe cg13989295) 
 Illumina 450 array 
 Blood 
 Cell type 
composition: yes 
 Consideration of 
genotype: yes  
 3T 
 Structural, T1 
 Cortical 
thicknesses 
 FreeSurfer 
 Negative associations between SKA2 DNAm and cortical 
thickness in prefrontal regions: left frontal pole, SFG and 
rostral middle frontal gyrus; right frontal pole, SFG, and 
right OFC/IFG pars orbitalis and rostral MFG.  
 Mediation was significant for right OFC and rostral MFG 
cluster, and for left prefrontal cluster. Mediation effect not 
significant for the right frontal pole/SFG cluster, though 
direction of association was consistent.  
Wolf et al., 
2016 
United States 
‡ 
 PTSD  
 Cases, 
n=281(247M) 
 Cases, mean 
age 31.9 years 
 Epigenome-wide: 
Illumina 450 array, 
Horvath/Hannum 
DNAm age  
Blood 
 Cell type 
composition: yes  
 Consideration of 
genotype: yes 
 3T 
 Diffusion 
 FA/RD/MD/AxD in 
right frontal cortex, 
left frontal cortex, 
genu of corpus 
callosum 
 FreeSurfer/TBSS 
Subset (n=241): 
 Accelerated Hannum DNAm age associated with 
decreased FA, increased RD and MD in genu of corpus 
callosum 
 Positive association between DNAm age acceleration and 
RD and MD in genu of corpus callosum 
 Negative association between DNAn age acceleration and 
FA in the genu of corpus callosum. 
 No associations found with Horvath DNAm age. 
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Schechter et 
al., 2017 
Switzerland † 
 Inter-personal 
violence related 
PTSD  
 Cases, n=18F; 
controls, n=17F 
 Cases, mean 
age 33.5 years; 
controls, mean 
35.6 years 
 
 
 Candidate: 
serotonin receptor 
3A methylation 
(HTR3A) – 7 CpG 
sites in the 
promoter region 
 Saliva 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 Field strength: NR  
 fMRI task: video 
stimuli depicting 
neutral, menacing, 
and male-female 
prosocial 
interactions.  
 Neural activity in 
maternal brain 
regions association 
with emotion 
regulation 
 Batch 
programming 
based on SPM8 
 Negative association between DNAm at CpG 2 III site and 
neural activity in response to menacing vs prosocial 
stimuli: dorsomedial PFC, dACC, bilateral dorsolateral 
prefrontal gyrus, left prefrontal gyrus, left temporal pole, left 
STG, left MTG; posterior cingulate cortex; left cuneus, V1; 
cerebellum; right brainstem.  
 Negative association between DNAm at 5HT3A CpG 2 III 
site and neural activity in response to menacing vs neutral 
stimuli: dmPFC, left dlPFC, left temporal pole, left middle 
temporal gyrus.  
Mcnerney et 
al., 2018 
United States 
 Veterans risk of 
meeting PTSD 
diagnostic 
criteria 
 Cases, n= 67 
(59M) 
 Cases, mean 46 
years 
 Candidate: NR3C1-
1F – promoter 
binding sites for 
transcription factor 
NGF1A 
 Saliva 
 Cell type 
composition: NR  
 Consideration of 
genotype: NR 
 3T 
 Structural, FSPGR 
 Intracranial volume 
and hippocampal 
volume 
 FreeSurfer 
 Positive associations between hippocampal volume and 
DNAm of NR3C1 gene in low scorers on the PTSD 
checklist (Civilian version 4; PCL-C), unlikely to meet 
PTSD diagnostic criteria).  
 Associations were not significant for those who scored 
highly on the PCL-C.  
 
† Overlapping cohort 
‡ Overlapping cohort 
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Table 9. Miscellaneous: healthy adults, emotion processing, social anxiety disorder, Cushing’s syndrome. 
Author, 
Country 
Sample 
characteristics 
 Condition 
 Cases (male); 
controls (male) 
 Age 
 Epigenome-
wide/candidate, 
platform 
 Tissue sampled 
 Correction for cell 
sub-type 
distribution 
 Consideration of 
genotype 
 MRI field strength 
 Modality  
 Image feature(s) 
 Analysis method 
Main Findings 
 
 
Ursini et al., 
2011 
Italy 
 Healthy 
participants 
 Cases, 
n=84(32M) 
 Cases, mean 
age 25.9 years 
 Candidate: COMT 
rs4680 (C2) and 
gene promoter (3 
CpGs in the 
promoter) 
 Peripheral blood 
mononuclear cells 
 Cell type 
composition: NR  
 Consideration of 
genotype: yes 
 3T  
 fMRI task: N-back 
task–working 
memory 
 BOLD responses in 
the bilateral 
prefrontal cortex 
 SPM5 
Val/Val genotype:  
 Negative association between C2 DNAm and bilateral 
PFC (BA 45/13 and BA47) activity during task  
 Increased stress and lower C2 DNAm related to greater 
activity in bilateral PFC (BA10/47; BA44/45) during 
working memory task  
 No significant relationship was found between DNAm of 
sites in the COMT promoter or in LINE-1 and working 
memory related PFC activity in any other genotype 
group or in the whole sample. 
Jack et al., 
2012 
United States 
 Healthy 
participants 
 Cases, 
n=42(23M) 
 Cases, mean 
age 21.9 years 
 Candidate: OXTR-
coding strand 
including site -934 
 Blood 
(mononuclear cells) 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T  
 fMRI task: social 
perception task 
(animacy versus 
random movement)  
 whole brain: BOLD 
activity 
 FSL (FEAT) 
 OXTR DNAm positively associated with activity in left 
STG, supramarginal gyrus, and right dACC. 
 Controlling for sex: OXTR DNAm positively associated 
with activity in the left STG and right dACC. No 
difference between men and women. 
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Vukojevic et 
al., 2014 
Switzerland 
 Healthy 
participants 
 Cases, 
n=72(25M) 
 Cases, median 
age 23 years  
 
 Candidate: NR3C1 
CpG3 
 Saliva 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T  
 fMRI task: N-back 
task–working 
memory task 
 Brain activation 
 SPM8 
 
 
 
 Women: no significant associations between NR3C1 
CpG3 DNAm and brain activation during fMRI task.  
 Men: positive associations between DNAm at NR3C1 
CpG3 and brain activity related to successful 
recognition of previously seen pictures: right 
hemisphere pars orbitalis, right hemisphere pars 
triangularis of the inferior frontal gyrus; near superior 
temporal cortex; left hemisphere cuneus, left 
hemisphere pericalcarine; near superior frontal cortex. 
Nikolova et al., 
2014 
United States 
 Healthy 
participants, 
Discovery set 
n=80(38M); 
replication set: 
96 (48M)  
 Discovery set 
mean age 19.7 
years; 
replication set 
13.6 years 
 Candidate: 
SLC6A4; 20 CpG 
sites in promoter 
region 
 Discovery: saliva 
 Replication: blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes 
 3T 
 fMRI task: 
emotional faces 
processing  
 BOLD - amygdala 
reactivity to threat 
(angry/fearful faces 
vs shapes).  
 SPM8 
 Positive association between SLC6A4 DNAm and left 
amygdala reactivity in response to threat stimuli; right 
amygdala did not reach statistical significance. 
 The CpG with the strongest association across both 
hemispheres is CpG14. 
 Findings consistent in discovery and replication sets 
Dannlowski et 
al., 2014 
Germany 
 Healthy 
participants 
 Cases, 
n=189(90M) 
 Two 
independent 
samples: sample 
1 n=94(42M); 
sample 2 
n=95(46M) 
 Sample 1 mean 
age 36.9 years; 
sample 2 mean 
age 34.2 years 
 Candidate: 
SLC6A4 AluJb 
element – mean 
methylation of 8 
investigated sites 
 Blood 
 Cell type 
composition: NR 
 Genotype: yes  
 
 
 Field strength: NR 
 Structural, T1  
 VBM-ROI volumes: 
hippocampus, 
anterior cingulate 
cortex, amygdala 
 VBM – whole brain. 
 VBM8/SPM8  
 
 Positive association between AluJb DNAm in the 
SLC6A4 gene and bilateral hippocampal grey matter 
volume in ROI analysis in both samples. In sample 1 
peak coordinates cluster extended into the bilateral 
amygdala. This was not the case in sample 2, but was 
the case in the combined sample. 
 Whole brain analysis: positive association clusters 
where a positive association is also found: bilateral 
insula, right putamen, amygdala and caudate, and left 
superior occipital gyrus, bilateral hippocampus.  
 No areas showed a negative association between 
DNAm rates and grey matter volume. Jo
urn
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Puglia et al., 
2015 
United States 
 Healthy 
participants 
 Cases, 
n=98(42M) 
 Cases, mean 
age 22.8 years 
 Candidate: OXTR 
CpG site at position 
-934 relative to 
TSS 
 Peripheral blood 
mononuclear cells 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 fMRI task: 
emotional face 
matching task. 
 BOLD - ROI 
analysis  
 PPI/FEAT (FSL) 
 Positive association between OXTR DNAm and BOLD 
in the left amygdala in Faces versus Ovals. No 
association in right amygdala. 
 Higher OXTR DNAm predicted decreased levels of 
functional connectivity on tasks involving affect 
appraisal and emotion regulation between right 
amygdala and brain regions involved in emotional 
regulation including insular cortex, cingulate cortex, 
orbitofrontal cortex as well as regions associated with 
face perception e.g fusiform gyrus. Left amygdala 
showed no significant voxels. 
Ziegler et al., 
2015 
Germany 
 Social anxiety 
disorder 
 Cases, n=25(F) 
 Cases, mean 
age 28.8 years 
 
 Candidate: OXTR 
gene exon 3 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes 
 3T  
 fMRI task: social 
phobia related 
verbal stimuli 
 Amygdala 
responsiveness  
 SPM8 
 In SAD patients (n=25F): negative association between 
OXTR DNAm and amygdala responsiveness in social 
phobia vs negative words or neutral words. 
Muehlhan et 
al., 2015 
Germany 
 Healthy 
participants 
 Cases, 
n=74(45M) 
 Cases (male), 
mean age 23.6 
years; cases 
(female), mean 
age 23.2 years 
 Candidate: 
SLC6A4- mean 
methylation score 
at the promoter 
 Blood  
 Cell type 
composition: NR 
 Consideration of 
genotype: yes  
 3T  
 fMRI: resting state 
 SPM12 
Positive associations between SLC6A4 DNAm and 
amygdala RS functional coupling with nodes of the 
salience network: 
 Right amygdala: right SMA and left dACC, left putamen 
and left insula, right IFG, right putamen, right insula 
 Left amygdala: right dACC, left ACC, left SMA 
Ursini et al., 
2016 
Italy 
 Healthy 
participants 
 Cases, n=141 
 Age: NR 
 Candidate: BDNF - 
rs6265 methylation 
status  
 Blood 
 Cell type 
composition: NR  
 Consideration of 
genotype: yes 
 3T 
 fMRI task: N-back 
task, working 
memory  
 SPM8 
Analysis carried out in 141 healthy subjects: 
 Positive association between BDNF rs6265 DNAm and 
left prefrontal activity 
 Val/Val genotype: greater DNAm is associated with 
reduced activity in the PFC (BA46) subjects with 
hypoxia related obstetric complications (assessed using 
the McNeil-Sjöström Scale) compared to those without. 
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 Val/Met genotype: lower DNAm is associated with 
reduced activity in the prefrontal cortex (BA46) in 
subjects with hypoxia related obstetric complications 
compared to those without. 
Haas et al., 
2016 
United States 
 Healthy 
participants  
 Cases, 
n=121(52M) 
 Cases, mean 
age 21.3 years 
 
 Candidate: OXT - 
average OXT DNA 
methylation across 
nine CpG cites 
 Saliva 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 Structural, T1  
 fMRI task: 
Emotional 
perspective taking 
task; Emotion 
attribution task 
 VBM - SPM8 
 Emotional perspective task: Negative association 
between OXT DNAm and activity in the R superior 
temporal sulcus during emotional perspective taking;  
 Emotion attribution task: negative association in the 
emotion attribution between OXT DNAm and activity in: 
right STS, right fusiform gyrus/middle occipital gyrus, 
right inferior frontal gyrus; left fusiform; 
 Negative association between OXT DNAm and grey 
matter volume in right fusiform gyrus 
Resmini et al., 
2016 
Spain 
 Cushing’s 
syndrome 
 Cases, n=32; 
controls, n=32 
 Cases: mean 
age 45 years; 
controls, mean 
age 44 years 
 Candidate: FKBP5 
- intronic regions 
 Blood 
 Cell type 
composition: NR 
 Consideration of 
genotype: yes 
 3T 
 Structural, T1  
 Hippocampal 
volume 
 FreeSurfer 
 
 Cases: positive association between Intron 2 region 2 
CpG3 DNAm and bilateral hippocampal volume 
  
Ismaylova et 
al., 2017 
Canada 
 Healthy 
participants 
 Cases 40(14M) 
 At time of blood 
sampling: 27 
 At time of 
saliva/buccal 
sampling: mean 
33.7 years 
 
 Candidate: 
SLC6A4 – 
promoter mean 
methylation score 
of 10 CpG sites 
 (blood/saliva/buccal
) 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T   
 fMRI task: 
Emotional face 
processing task  
 fMRI resting state 
 Structural, T1 
 WB analysis and 
10 ROIs grey 
matter volumes, 
functional 
connectivity 
 VBM/SPM12/Conn 
functional 
connectivity toolbox  
 Positive associations between SLC6A4 promoter 
DNAm and grey matter volumes, which varied by tissue 
type: 
- Blood: right superior frontal grey matter; 
- Saliva: left superior frontal gyrus;  
- Buccal cells: left superior frontal gyrus, left inferior 
frontal gyrus, right ACC.  
 Positive association between blood SCL6A4 DNAm 
and RS connectivity between: RLP and bilateral frontal 
poles and SFG; RLP and left lateral occipital cortex 
 Positive associations between buccal SLC6A4 
promoter DNAm and RS connectivity between the RLP 
with right lateral occipital cortex and right angular gyrus, 
ACC, right frontal pole and mPFC  
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 No significant associations were found for task-based 
fMRI  
Wiemerslage 
et al., 2017 
Sweden  
 Orexigenia 
among healthy 
participants  
 Cases, n=23(all 
M) 
 Cases, mean 
age 26 years 
 
 Candidate: KLF13 - 
cg07814318 probe 
methylation 
 Blood 
 Cell type 
composition: yes  
 Consideration of 
genotype: NR 
 3T 
 fMRI resting state 
and task: virtual 
high or low-calorie 
food 
 WB 
 SPM8 
 Negative associations between KLF13 DNAm and 
neural activity in response to images high calorie food 
in comparison to images of low-calorie foods in: left 
claustrum and insula, bilateral cingulate gyrus, right 
precentral gyrus and claustrum, right MFG, SFG and 
medial FG.  
 Positive associations between DNAm and RS activity in 
the right caudate and putamen, left lingual gyrus and 
fusiform gyrus.  
Ismaylova et 
al., 2018 
Canada  
 Fronto-limbic 
brain responses 
to sadness/fear 
 Cases, n=96 
monozygotic 
twins (21M 
pairs) 
 Cases, mean 
age 15 years 
 Candidate: 
SLC6A4 – 
promoter CpG 5-14 
 Saliva 
 Cell type 
composition: NR 
 Consideration of 
genotype: NR 
 3T 
 fMRI task: 
Emotional face 
processing task  
 ROI functional 
connectivity 
 SPM8/CONN 
toolbox 
 Sad condition: Positive association between SLC6A4 
DNAm and OFC activation. Positive association 
between methylation and functional connectivity 
between left amygdala and the ACC and the left 
amygdala and the right OFC  
 Fearful condition: positive association between 
SLC6A4methylation and functional connectivity 
between ACC and both the left amygdala and left 
insula. 
Freytag et al., 
2017 
Germany/ 
Switzerland 
 Healthy cohort 
n=533(222M) of 
whom 514 have 
imaging. 
 Mean age at 
MRI: mean 22.9 
years; mean age 
at blood 
sampling 23.9 
years  
 Epigenome-wide: 
Illumina 450 array 
 Blood 
 Cell type 
composition: 
Methylomic 
profiling sample: 
yes; Replication 
cohort: none 
reported 
 Consideration of 
genotype: yes 
 1.5T/3T 
 Structural, T1 
 Cortical thickness 
 FreeSurfer 
 Independent component analysis (ICA) applied to 
decompose methylation profiles.  
 Negative association between the second independent 
component (ICA2) DNAm and cortical thickness. ICA2 
DNAm partially mediates the relationship between 
chronological age and global cortical thickness.  
 Negative association between ICA2 and F6 (identified 
through exploratory factor analysis (EFA) of variation in 
cortical thicknesses); F6 accounts for 4% of variance in 
cortical thickness measures - spatial pattern comprising 
mainly temporal areas (loadings >0.3) with highest 
loadings in L and R temporal poles and entorhinal 
cortices.  
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